{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T16:57:52Z","timestamp":1795021072624,"version":"4.10.1"},"reference-count":353,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation","doi-asserted-by":"crossref","award":["82072999"],"award-info":[{"award-number":["82072999"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The WNT signaling pathway, a fundamental molecular network regulating cell proliferation, differentiation, and stemness, plays a critical role in tumorigenesis, cancer progression, and therapeutic resistance. Given its crucial regulatory roles in tumors, WNT signaling pathway has been identified as effective targets for cancer treatment. However, the current clinical efficacy of WNT signaling pathway-targeted anti-tumor therapies remains suboptimal. Based on research investigating the role of WNT signaling pathway in cancer, we systematically discuss the molecular mechanisms of WNT signaling in cancer (including both canonical and non-canonical signaling pathways), the role of WNT signaling in different cancer types, highlighting distinct potential therapeutic approaches targeting WNT signaling. We also comprehensively review innovative strategies targeting WNT signaling, including Porcupine (PORCN) inhibitors, Tankyrase (TNKS) inhibitor, Frizzled (FZD)-targeted monoclonal antibodies, \u03b2-catenin\/TCF transcriptional complex inhibitors, and natural bioactive compounds and drug repositioning etc., critically evaluating their preclinical efficacy and limitations. We emphasize the need for and challenges in developing WNT-targeted therapies including refining the specificity of WNT signaling pathway-targeted therapies, developing biomarkers for patient selection, and exploring synergies between WNT inhibitors and other therapeutic modalities such as immune checkpoint blockers. These advances aim to enable personalized precision therapy and revolutionize cancer treatment paradigms in the future.<\/jats:p>","DOI":"10.1186\/s43556-025-00327-x","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:45:56Z","timestamp":1761101156000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["WNT signaling in cancer: molecular mechanisms and potential therapies"],"prefix":"10.1186","volume":"6","author":[{"given":"Jiaqi","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingru","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dequan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5173-0781","authenticated-orcid":false,"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"issue":"10","key":"327_CR1","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1158\/2159-8290.Cd-21-0190","volume":"11","author":"MJ Parsons","year":"2021","unstructured":"Parsons MJ, Tammela T, Dow LE. WNT as a driver and dependency in cancer. Cancer Discov. 2021;11(10):2413\u201329. https:\/\/doi.org\/10.1158\/2159-8290.Cd-21-0190.","journal-title":"Cancer Discov"},{"issue":"3","key":"327_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2023.04.042","volume":"11","author":"M Yu","year":"2024","unstructured":"Yu M, Qin K, Fan J, Zhao G, Zhao P, Zeng W, et al. The evolving roles of Wnt signaling in stem cell proliferation and differentiation, the development of human diseases, and therapeutic opportunities. Genes Dis. 2024;11(3):101026. https:\/\/doi.org\/10.1016\/j.gendis.2023.04.042.","journal-title":"Genes Dis"},{"issue":"1","key":"327_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-016-0541-3","volume":"15","author":"EK Onyido","year":"2016","unstructured":"Onyido EK, Sweeney E, Nateri AS. Wnt-signalling pathways and microRNAs network in carcinogenesis: experimental and bioinformatics approaches. Mol Cancer. 2016;15(1):56. https:\/\/doi.org\/10.1186\/s12943-016-0541-3.","journal-title":"Mol Cancer"},{"issue":"7","key":"327_CR4","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nrd4233","volume":"13","author":"M Kahn","year":"2014","unstructured":"Kahn M. Can we safely target the WNT pathway? Nat Rev Drug Discov. 2014;13(7):513\u201332. https:\/\/doi.org\/10.1038\/nrd4233.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"327_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3350\/cmh.2022.0058","volume":"29","author":"G Zou","year":"2023","unstructured":"Zou G, Park JI. Wnt signaling in liver regeneration, disease, and cancer. Clin Mol Hepatol. 2023;29(1):33\u201350. https:\/\/doi.org\/10.3350\/cmh.2022.0058.","journal-title":"Clin Mol Hepatol"},{"issue":"8","key":"327_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110454","volume":"27","author":"J Yu","year":"2024","unstructured":"Yu J, Liao PJ, Keller TH, Cherian J, Virshup DM, Xu W. Ultra-large scale virtual screening identifies a small molecule inhibitor of the Wnt transporter Wntless. iScience. 2024;27(8):110454. https:\/\/doi.org\/10.1016\/j.isci.2024.110454.","journal-title":"iScience"},{"issue":"1","key":"327_CR7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12943-020-01276-5","volume":"19","author":"X Xu","year":"2020","unstructured":"Xu X, Zhang M, Xu F, Jiang S. Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities. Mol Cancer. 2020;19(1):165. https:\/\/doi.org\/10.1186\/s12943-020-01276-5.","journal-title":"Mol Cancer"},{"key":"327_CR8","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.96743","author":"ES Bruguera","year":"2025","unstructured":"Bruguera ES, Mahoney JP, Weis WI. The co-receptor Tetraspanin12 directly captures Norrin to promote ligand-specific \u03b2-catenin signaling. Elife. 2025. https:\/\/doi.org\/10.7554\/eLife.96743.","journal-title":"Elife"},{"key":"327_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217271","volume":"604","author":"L Yu","year":"2024","unstructured":"Yu L, Wei W, Lv J, Lu Y, Wang Z, Cai C. FABP4-mediated lipid metabolism promotes TNBC progression and breast cancer stem cell activity. Cancer Lett. 2024;604:217271. https:\/\/doi.org\/10.1016\/j.canlet.2024.217271.","journal-title":"Cancer Lett"},{"issue":"7","key":"327_CR10","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1080\/09168451.2019.1606697","volume":"83","author":"F Zhang","year":"2019","unstructured":"Zhang F, Li Y, Xu W, He L, Tan Y, Xu H. Long non-coding RNA ZFAS1 regulates the malignant progression of gastric cancer via the microRNA-200b-3p\/Wnt1 axis. Biosci Biotechnol Biochem. 2019;83(7):1289\u201399. https:\/\/doi.org\/10.1080\/09168451.2019.1606697.","journal-title":"Biosci Biotechnol Biochem"},{"issue":"1","key":"327_CR11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.5582\/irdr.2020.01018","volume":"9","author":"C Peng","year":"2020","unstructured":"Peng C, Lu Y, Ren X, Wang Y, Zhang S, Chen M, et al. Comprehensive bioinformatic analysis of Wnt1 and Wnt1-associated diseases. Intractable Rare Dis Res. 2020;9(1):14\u201322. https:\/\/doi.org\/10.5582\/irdr.2020.01018.","journal-title":"Intractable Rare Dis Res"},{"issue":"6","key":"327_CR12","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.4251\/wjgo.v16.i6.2769","volume":"16","author":"XZ Zhang","year":"2024","unstructured":"Zhang XZ, Mo XC, Wang ZT, Sun R, Sun DQ. N-glycosylation of Wnt3 regulates the progression of hepatocellular carcinoma by affecting Wnt\/\u03b2-catenin signal pathway. World J Gastrointest Oncol. 2024;16(6):2769\u201380. https:\/\/doi.org\/10.4251\/wjgo.v16.i6.2769.","journal-title":"World J Gastrointest Oncol"},{"issue":"5","key":"327_CR13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.tips.2024.03.003","volume":"45","author":"G Schulte","year":"2024","unstructured":"Schulte G, Scharf MM, Bous J, Voss JH, Gr\u00e4tz L, Kozielewicz P. Frizzleds act as dynamic pharmacological entities. Trends Pharmacol Sci. 2024;45(5):419\u201329. https:\/\/doi.org\/10.1016\/j.tips.2024.03.003.","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"327_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-021-01643-6","volume":"21","author":"Y Li","year":"2021","unstructured":"Li Y, Liu Z, Zhang Y. Expression and prognostic impact of FZDs in pancreatic adenocarcinoma. BMC Gastroenterol. 2021;21(1):79. https:\/\/doi.org\/10.1186\/s12876-021-01643-6.","journal-title":"BMC Gastroenterol"},{"issue":"6","key":"327_CR15","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1053\/j.gastro.2023.01.041","volume":"164","author":"J Wang","year":"2023","unstructured":"Wang J, Yu H, Dong W, Zhang C, Hu M, Ma W, et al. N6-methyladenosine-mediated up-regulation of FZD10 regulates liver cancer stem cells\u2019 properties and lenvatinib resistance through WNT\/\u03b2-catenin and hippo signaling pathways. Gastroenterology. 2023;164(6):990\u20131005. https:\/\/doi.org\/10.1053\/j.gastro.2023.01.041.","journal-title":"Gastroenterology"},{"issue":"15","key":"327_CR16","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1111\/bph.16373","volume":"181","author":"B Li","year":"2024","unstructured":"Li B, Li X, Jiang Z, Zhou D, Feng Y, Chen G, et al. LncRNA XIST modulates miR-328-3p ectopic expression in lung injury induced by tobacco-specific lung carcinogen NNK both in vitro and in vivo. Br J Pharmacol. 2024;181(15):2509\u201327. https:\/\/doi.org\/10.1111\/bph.16373.","journal-title":"Br J Pharmacol"},{"key":"327_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25158083","author":"JK Nag","year":"2024","unstructured":"Nag JK, Appasamy P, Malka H, Sedley S, Bar-Shavit R. New target(s) for RNF43 regulation: implications for therapeutic strategies. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25158083.","journal-title":"Int J Mol Sci"},{"key":"327_CR18","doi-asserted-by":"publisher","unstructured":"Bugter JM, van Kerkhof P, Jordens I, Janssen E, Tran Ngoc Minh T, Iglesias van Montfort D, et al. E3 ligases RNF43 and ZNRF3 display differential specificity for endocytosis of Frizzled receptors. Life Sci Alliance. 2024;7(9). https:\/\/doi.org\/10.26508\/lsa.202402575.","DOI":"10.26508\/lsa.202402575"},{"issue":"1","key":"327_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02159-1","volume":"10","author":"B Cui","year":"2025","unstructured":"Cui B, Luo H, He B, Liu X, Lv D, Zhang X, et al. Gut dysbiosis conveys psychological stress to activate LRP5\/\u03b2-catenin pathway promoting cancer stemness. Signal Transduct Target Ther. 2025;10(1):79. https:\/\/doi.org\/10.1038\/s41392-025-02159-1.","journal-title":"Signal Transduct Target Ther"},{"issue":"16","key":"327_CR20","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1038\/s41388-022-02259-0","volume":"41","author":"Z Rong","year":"2022","unstructured":"Rong Z, Zhang L, Li Z, Xiao Z, Duan Y, Ren X, et al. SIK2 maintains breast cancer stemness by phosphorylating LRP6 and activating Wnt\/\u03b2-catenin signaling. Oncogene. 2022;41(16):2390\u2013403. https:\/\/doi.org\/10.1038\/s41388-022-02259-0.","journal-title":"Oncogene"},{"issue":"3","key":"327_CR21","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.ajpath.2021.11.007","volume":"192","author":"X Nie","year":"2022","unstructured":"Nie X, Wang H, Wei X, Li L, Xue T, Fan L, et al. LRP5 promotes gastric cancer via activating canonical Wnt\/\u03b2-catenin and glycolysis pathways. Am J Pathol. 2022;192(3):503\u201317. https:\/\/doi.org\/10.1016\/j.ajpath.2021.11.007.","journal-title":"Am J Pathol"},{"issue":"9","key":"327_CR22","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1002\/jcb.25956","volume":"118","author":"J Ma","year":"2017","unstructured":"Ma J, Lu W, Chen D, Xu B, Li Y. Role of wnt co-receptor LRP6 in triple negative breast cancer cell migration and invasion. J Cell Biochem. 2017;118(9):2968\u201376. https:\/\/doi.org\/10.1002\/jcb.25956.","journal-title":"J Cell Biochem"},{"issue":"5","key":"327_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036565","volume":"7","author":"EK Tung","year":"2012","unstructured":"Tung EK, Wong BY, Yau TO, Ng IO. Upregulation of the Wnt co-receptor LRP6 promotes hepatocarcinogenesis and enhances cell invasion. PLoS ONE. 2012;7(5):e36565. https:\/\/doi.org\/10.1371\/journal.pone.0036565.","journal-title":"PLoS ONE"},{"key":"327_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.906260","volume":"12","author":"S Ghatak","year":"2022","unstructured":"Ghatak S, Hascall VC, Karamanos N, Markwald RR, Misra S. Chemotherapy induces feedback up-regulation of CD44v6 in colorectal cancer initiating cells through \u03b2-catenin\/MDR1 signaling to sustain chemoresistance. Front Oncol. 2022;12:906260. https:\/\/doi.org\/10.3389\/fonc.2022.906260.","journal-title":"Front Oncol"},{"issue":"6","key":"327_CR25","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","volume":"169","author":"R Nusse","year":"2017","unstructured":"Nusse R, Clevers H. Wnt\/\u03b2-catenin signaling, disease, and emerging therapeutic modalities. Cell. 2017;169(6):985\u201399. https:\/\/doi.org\/10.1016\/j.cell.2017.05.016.","journal-title":"Cell"},{"key":"327_CR26","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1146\/annurev-biochem-040320-103615","volume":"91","author":"EY Rim","year":"2022","unstructured":"Rim EY, Clevers H, Nusse R. The Wnt pathway: from signaling mechanisms to synthetic modulators. Annu Rev Biochem. 2022;91:571\u201398. https:\/\/doi.org\/10.1146\/annurev-biochem-040320-103615.","journal-title":"Annu Rev Biochem"},{"issue":"5","key":"327_CR27","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/s1097-2765(01)00241-6","volume":"7","author":"J Liu","year":"2001","unstructured":"Liu J, Stevens J, Rote CA, Yost HJ, Hu Y, Neufeld KL, et al. Siah-1 mediates a novel beta-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein. Mol Cell. 2001;7(5):927\u201336. https:\/\/doi.org\/10.1016\/s1097-2765(01)00241-6.","journal-title":"Mol Cell"},{"issue":"1","key":"327_CR28","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13048-019-0596-z","volume":"12","author":"VHL Nguyen","year":"2019","unstructured":"Nguyen VHL, Hough R, Bernaudo S, Peng C. Wnt\/\u03b2-catenin signalling in ovarian cancer: insights into its hyperactivation and function in tumorigenesis. J Ovarian Res. 2019;12(1):122. https:\/\/doi.org\/10.1186\/s13048-019-0596-z.","journal-title":"J Ovarian Res"},{"key":"327_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13081830","author":"Y Krutsenko","year":"2021","unstructured":"Krutsenko Y, Singhi AD, Monga SP. \u03b2-catenin activation in hepatocellular cancer: implications in biology and therapy. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13081830.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"327_CR30","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3892\/ol.2024.14748","volume":"29","author":"T Wang","year":"2025","unstructured":"Wang T, Fu J, Huang Y, Fu C. Mechanism of APC truncation involved in colorectal cancer tumorigenesis (Review). Oncol Lett. 2025;29(1):2. https:\/\/doi.org\/10.3892\/ol.2024.14748.","journal-title":"Oncol Lett"},{"issue":"6","key":"327_CR31","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1053\/j.gastro.2012.08.047","volume":"143","author":"GJ Feng","year":"2012","unstructured":"Feng GJ, Cotta W, Wei XQ, Poetz O, Evans R, Jard\u00e9 T, et al. Conditional disruption of Axin1 leads to development of liver tumors in mice. Gastroenterology. 2012;143(6):1650\u20139. https:\/\/doi.org\/10.1053\/j.gastro.2012.08.047.","journal-title":"Gastroenterology"},{"issue":"6","key":"327_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0304607","volume":"19","author":"R Zhang","year":"2024","unstructured":"Zhang R, Li S, Schippers K, Eimers B, Niu J, Hornung BVH, et al. Unraveling the impact of AXIN1 mutations on HCC development: insights from CRISPR\/Cas9 repaired AXIN1-mutant liver cancer cell lines. PLoS ONE. 2024;19(6):e0304607. https:\/\/doi.org\/10.1371\/journal.pone.0304607.","journal-title":"PLoS ONE"},{"issue":"6","key":"327_CR33","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1158\/0008-5472.Can-04-3642","volume":"65","author":"AV Ougolkov","year":"2005","unstructured":"Ougolkov AV, Fernandez-Zapico ME, Savoy DN, Urrutia RA, Billadeau DD. Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells. Cancer Res. 2005;65(6):2076\u201381. https:\/\/doi.org\/10.1158\/0008-5472.Can-04-3642.","journal-title":"Cancer Res"},{"issue":"1","key":"327_CR34","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s12276-024-01374-0","volume":"57","author":"S Tao","year":"2025","unstructured":"Tao S, Pu Y, Yang EJ, Ren G, Shi C, Chen LJ, et al. Inhibition of GSK3\u03b2 is synthetic lethal with FHIT loss in lung cancer by blocking homologous recombination repair. Exp Mol Med. 2025;57(1):167\u201383. https:\/\/doi.org\/10.1038\/s12276-024-01374-0.","journal-title":"Exp Mol Med"},{"issue":"1","key":"327_CR35","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1158\/1535-7163.Mct-20-0497","volume":"20","author":"BA Borden","year":"2021","unstructured":"Borden BA, Baca Y, Xiu J, Tavora F, Winer I, Weinberg BA, et al. The landscape of glycogen synthase kinase-3 beta genomic alterations in cancer. Mol Cancer Ther. 2021;20(1):183\u201390. https:\/\/doi.org\/10.1158\/1535-7163.Mct-20-0497.","journal-title":"Mol Cancer Ther"},{"issue":"9","key":"327_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07039-0","volume":"15","author":"J Zhou","year":"2024","unstructured":"Zhou J, Wang X, Li Z, Wang F, Cao L, Chen X, et al. PIM1 kinase promotes EMT-associated osimertinib resistance via regulating GSK3\u03b2 signaling pathway in EGFR-mutant non-small cell lung cancer. Cell Death Dis. 2024;15(9):644. https:\/\/doi.org\/10.1038\/s41419-024-07039-0.","journal-title":"Cell Death Dis"},{"issue":"5","key":"327_CR37","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1002\/ijc.22368","volume":"120","author":"IC Tsai","year":"2007","unstructured":"Tsai IC, Woolf M, Neklason DW, Branford WW, Yost HJ, Burt RW, et al. Disease-associated casein kinase I delta mutation may promote adenomatous polyps formation via a Wnt\/beta-catenin independent mechanism. Int J Cancer. 2007;120(5):1005\u201312. https:\/\/doi.org\/10.1002\/ijc.22368.","journal-title":"Int J Cancer"},{"key":"327_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-231","volume":"13","author":"B Schittek","year":"2014","unstructured":"Schittek B, Sinnberg T. Biological functions of casein kinase 1 isoforms and putative roles in tumorigenesis. Mol Cancer. 2014;13:231. https:\/\/doi.org\/10.1186\/1476-4598-13-231.","journal-title":"Mol Cancer"},{"issue":"5","key":"327_CR39","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/s1097-2765(03)00427-1","volume":"12","author":"HC Wong","year":"2003","unstructured":"Wong HC, Bourdelas A, Krauss A, Lee HJ, Shao Y, Wu D, et al. Direct binding of the PDZ domain of Dishevelled to a conserved internal sequence in the C-terminal region of Frizzled. Mol Cell. 2003;12(5):1251\u201360. https:\/\/doi.org\/10.1016\/s1097-2765(03)00427-1.","journal-title":"Mol Cell"},{"issue":"11","key":"327_CR40","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nrurol.2017.144","volume":"14","author":"V Murillo-Garz\u00f3n","year":"2017","unstructured":"Murillo-Garz\u00f3n V, Kypta R. Wnt signalling in prostate cancer. Nat Rev Urol. 2017;14(11):683\u201396. https:\/\/doi.org\/10.1038\/nrurol.2017.144.","journal-title":"Nat Rev Urol"},{"issue":"1","key":"327_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","volume":"7","author":"J Liu","year":"2022","unstructured":"Liu J, Xiao Q, Xiao J, Niu C, Li Y, Zhang X, et al. Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther. 2022;7(1):3. https:\/\/doi.org\/10.1038\/s41392-021-00762-6.","journal-title":"Signal Transduct Target Ther"},{"key":"327_CR42","doi-asserted-by":"publisher","unstructured":"Wang L, Zhu R, Wen Z, Fan HS, Norwood-Jackson T, Jathan D, et al. Structural and Functional Insights into Dishevelled-Mediated Wnt Signaling. Cells. 2024;13(22). https:\/\/doi.org\/10.3390\/cells13221870.","DOI":"10.3390\/cells13221870"},{"issue":"23","key":"327_CR43","doi-asserted-by":"publisher","first-page":"24424","DOI":"10.18632\/aging.202300","volume":"12","author":"Y Yang","year":"2020","unstructured":"Yang Y, Jiang H, Li W, Chen L, Zhu W, Xian Y, et al. FOXM1\/DVL2\/Snail axis drives metastasis and chemoresistance of colorectal cancer. Aging (Albany NY). 2020;12(23):24424\u201340. https:\/\/doi.org\/10.18632\/aging.202300.","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"327_CR44","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.bbrc.2018.09.103","volume":"505","author":"B Zeng","year":"2018","unstructured":"Zeng B, Li Y, Feng Y, Lu M, Yuan H, Yi Z, et al. Downregulated miR-1247-5p associates with poor prognosis and facilitates tumor cell growth via DVL1\/Wnt\/\u03b2-catenin signaling in breast cancer. Biochem Biophys Res Commun. 2018;505(1):302\u20138. https:\/\/doi.org\/10.1016\/j.bbrc.2018.09.103.","journal-title":"Biochem Biophys Res Commun"},{"key":"327_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154793","volume":"250","author":"SH Alshahrani","year":"2023","unstructured":"Alshahrani SH, Rakhimov N, Rana A, Alsaab HO, Hjazi A, Adile M, et al. Dishevelled: an emerging therapeutic oncogene in human cancers. Pathol Res Pract. 2023;250:154793. https:\/\/doi.org\/10.1016\/j.prp.2023.154793.","journal-title":"Pathol Res Pract"},{"issue":"8","key":"327_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2013.28","volume":"2","author":"H Jung","year":"2013","unstructured":"Jung H, Kim BG, Han WH, Lee JH, Cho JY, Park WS, et al. Deubiquitination of dishevelled by Usp14 is required for Wnt signaling. Oncogenesis. 2013;2(8):e64. https:\/\/doi.org\/10.1038\/oncsis.2013.28.","journal-title":"Oncogenesis"},{"issue":"5307","key":"327_CR47","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1126\/science.275.5307.1790","volume":"275","author":"B Rubinfeld","year":"1997","unstructured":"Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P. Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science. 1997;275(5307):1790\u20132. https:\/\/doi.org\/10.1126\/science.275.5307.1790.","journal-title":"Science"},{"issue":"3","key":"327_CR48","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/s0092-8674(00)80112-9","volume":"86","author":"M Molenaar","year":"1996","unstructured":"Molenaar M, van de Wetering M, Oosterwegel M, Peterson-Maduro J, Godsave S, Korinek V, et al. XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell. 1996;86(3):391\u20139. https:\/\/doi.org\/10.1016\/s0092-8674(00)80112-9.","journal-title":"Cell"},{"key":"327_CR49","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/567305","volume":"2011","author":"X Tian","year":"2011","unstructured":"Tian X, Liu Z, Niu B, Zhang J, Tan TK, Lee SR, et al. E-cadherin\/\u03b2-catenin complex and the epithelial barrier. J Biomed Biotechnol. 2011;2011:567305. https:\/\/doi.org\/10.1155\/2011\/567305.","journal-title":"J Biomed Biotechnol"},{"key":"327_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/cells8101118","author":"CY Loh","year":"2019","unstructured":"Loh CY, Chai JY, Tang TF, Wong WF, Sethi G, Shanmugam MK, et al. The E-cadherin and N-cadherin switch in epithelial-to-mesenchymal transition: signaling, therapeutic implications, and challenges. Cells. 2019. https:\/\/doi.org\/10.3390\/cells8101118.","journal-title":"Cells"},{"issue":"1","key":"327_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02758-2","volume":"42","author":"D Wang","year":"2023","unstructured":"Wang D, Wu S, He J, Sun L, Zhu H, Zhang Y, et al. FAT4 overexpression promotes antitumor immunity by regulating the \u03b2-catenin\/STT3\/PD-L1 axis in cervical cancer. J Exp Clin Cancer Res. 2023;42(1):222. https:\/\/doi.org\/10.1186\/s13046-023-02758-2.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"327_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06409-2","volume":"23","author":"H Sun","year":"2025","unstructured":"Sun H, Zhang Y, Wang F, Wang Z, Zhang Y, Chen Y, et al. Sorbs3-\u03b2 suppresses lymph node metastasis in cervical cancer by promoting the ubiquitination of \u03b2-catenin. J Transl Med. 2025;23(1):406. https:\/\/doi.org\/10.1186\/s12967-025-06409-2.","journal-title":"J Transl Med"},{"issue":"6","key":"327_CR53","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.00380-20","volume":"41","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Liu H, Zhang Q, Zhang Z. Long Noncoding RNA LINC01006 Facilitates Cell Proliferation, Migration, and Epithelial-Mesenchymal Transition in Lung Adenocarcinoma via Targeting the MicroRNA 129\u20132-3p\/CTNNB1 Axis and Activating Wnt\/\u03b2-Catenin Signaling Pathway. Mol Cell Biol. 2021;41(6):e0038020. https:\/\/doi.org\/10.1128\/mcb.00380-20.","journal-title":"Mol Cell Biol"},{"issue":"6","key":"327_CR54","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.7150\/ijms.103024","volume":"22","author":"L Fen","year":"2025","unstructured":"Fen L, Yuanyuan W, Tian C, Yingying W, Yongping W, Mingwan Z, et al. Molecular network analysis of CPEB4 translational control and targeting CPEB4\/\u03b2-catenin to modulate invasion and migration of nasopharyngeal carcinoma cells. Int J Med Sci. 2025;22(6):1329\u201343. https:\/\/doi.org\/10.7150\/ijms.103024.","journal-title":"Int J Med Sci"},{"key":"327_CR55","doi-asserted-by":"publisher","DOI":"10.1111\/odi.15286","author":"Z You","year":"2025","unstructured":"You Z, Sima Z, Guo X, Li X, Feng Y, Du N, et al. Mutational landscape of ameloblastoma: analysis of BRAF and other key mutations in Chinese patients. Oral Dis. 2025. https:\/\/doi.org\/10.1111\/odi.15286.","journal-title":"Oral Dis"},{"issue":"8058","key":"327_CR56","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/s41586-025-08708-6","volume":"640","author":"THH Coorens","year":"2025","unstructured":"Coorens THH, Collord G, Jung H, Wang Y, Moore L, Hooks Y, et al. The somatic mutation landscape of normal gastric epithelium. Nature. 2025;640(8058):418\u201326. https:\/\/doi.org\/10.1038\/s41586-025-08708-6.","journal-title":"Nature"},{"issue":"1","key":"327_CR57","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41419-025-07502-6","volume":"16","author":"M Ding","year":"2025","unstructured":"Ding M, Ma C, Lin Y, Fang H, Xu Y, Wang S, et al. Therapeutic targeting de novo purine biosynthesis driven by \u03b2-catenin-dependent PPAT upregulation in hepatoblastoma. Cell Death Dis. 2025;16(1):179. https:\/\/doi.org\/10.1038\/s41419-025-07502-6.","journal-title":"Cell Death Dis"},{"issue":"1","key":"327_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2024.189232","volume":"1880","author":"Y Yan","year":"2025","unstructured":"Yan Y, Gong Y, Liang X, Xiong Q, Lin J, Wu Y, et al. Decoding \u03b2-catenin associated protein-protein interactions: emerging cancer therapeutic opportunities. Biochimica et Biophysica Acta (BBA). 2025;1880(1):189232. https:\/\/doi.org\/10.1016\/j.bbcan.2024.189232.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"12","key":"327_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101186","volume":"6","author":"BM Lehrich","year":"2024","unstructured":"Lehrich BM, Tao J, Liu S, Hirsch TZ, Yasaka TM, Cao C, et al. Development of mutated \u03b2-catenin gene signature to identify CTNNB1 mutations from whole and spatial transcriptomic data in patients with HCC. JHEP Rep. 2024;6(12):101186. https:\/\/doi.org\/10.1016\/j.jhepr.2024.101186.","journal-title":"JHEP Rep"},{"issue":"8","key":"327_CR60","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/pas.0000000000002402","volume":"49","author":"F Zhou","year":"2025","unstructured":"Zhou F, Qin L, Huang S, Lin W, Zhang H, Parkash V, et al. Pilomatrix-like high-grade endometrial carcinoma: an underdiagnosed entity with aggressive clinicopathologic features. Am J Surg Pathol. 2025;49(8):818\u201329. https:\/\/doi.org\/10.1097\/pas.0000000000002402.","journal-title":"Am J Surg Pathol"},{"key":"327_CR61","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.addr.2020.12.010","volume":"169","author":"M Caspi","year":"2021","unstructured":"Caspi M, Wittenstein A, Kazelnik M, Shor-Nareznoy Y, Rosin-Arbesfeld R. Therapeutic targeting of the oncogenic Wnt signaling pathway for treating colorectal cancer and other colonic disorders. Adv Drug Deliv Rev. 2021;169:118\u201336. https:\/\/doi.org\/10.1016\/j.addr.2020.12.010.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"327_CR62","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.cellsig.2013.11.021","volume":"26","author":"L Ring","year":"2014","unstructured":"Ring L, Neth P, Weber C, Steffens S, Faussner A. \u03b2-Catenin-dependent pathway activation by both promiscuous \u201ccanonical\u201d WNT3a-, and specific \u201cnoncanonical\u201d WNT4- and WNT5a-FZD receptor combinations with strong differences in LRP5 and LRP6 dependency. Cell Signal. 2014;26(2):260\u20137. https:\/\/doi.org\/10.1016\/j.cellsig.2013.11.021.","journal-title":"Cell Signal"},{"issue":"5","key":"327_CR63","doi-asserted-by":"publisher","first-page":"5609","DOI":"10.1007\/s11033-019-04895-4","volume":"46","author":"M Pashirzad","year":"2019","unstructured":"Pashirzad M, Fiuji H, Khazei M, Moradi-Binabaj M, Ryzhikov M, Shabani M, et al. Role of Wnt3a in the pathogenesis of cancer, current status and prospective. Mol Biol Rep. 2019;46(5):5609\u201316. https:\/\/doi.org\/10.1007\/s11033-019-04895-4.","journal-title":"Mol Biol Rep"},{"issue":"8","key":"327_CR64","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1158\/0008-5472.Can-18-2757","volume":"79","author":"K VanderVorst","year":"2019","unstructured":"VanderVorst K, Dreyer CA, Konopelski SE, Lee H, Ho HH, Carraway KL 3rd. Wnt\/PCP Signaling Contribution to Carcinoma Collective Cell Migration and Metastasis. Cancer Res. 2019;79(8):1719\u201329. https:\/\/doi.org\/10.1158\/0008-5472.Can-18-2757.","journal-title":"Cancer Res"},{"issue":"6","key":"327_CR65","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41581-021-00395-6","volume":"17","author":"E Torban","year":"2021","unstructured":"Torban E, Sokol SY. Planar cell polarity pathway in kidney development, function and disease. Nat Rev Nephrol. 2021;17(6):369\u201385. https:\/\/doi.org\/10.1038\/s41581-021-00395-6.","journal-title":"Nat Rev Nephrol"},{"issue":"36","key":"327_CR66","doi-asserted-by":"publisher","first-page":"5158","DOI":"10.1038\/onc.2017.126","volume":"36","author":"JH Wald","year":"2017","unstructured":"Wald JH, Hatakeyama J, Printsev I, Cuevas A, Fry WHD, Saldana MJ, et al. Suppression of planar cell polarity signaling and migration in glioblastoma by Nrdp1-mediated Dvl polyubiquitination. Oncogene. 2017;36(36):5158\u201367. https:\/\/doi.org\/10.1038\/onc.2017.126.","journal-title":"Oncogene"},{"issue":"32","key":"327_CR67","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1038\/onc.2011.528","volume":"31","author":"JN Anastas","year":"2012","unstructured":"Anastas JN, Biechele TL, Robitaille M, Muster J, Allison KH, Angers S, et al. A protein complex of SCRIB, NOS1AP and VANGL1 regulates cell polarity and migration, and is associated with breast cancer progression. Oncogene. 2012;31(32):3696\u2013708. https:\/\/doi.org\/10.1038\/onc.2011.528.","journal-title":"Oncogene"},{"issue":"9","key":"327_CR68","doi-asserted-by":"publisher","first-page":"4349","DOI":"10.1111\/jcmm.16497","volume":"25","author":"Y Li","year":"2021","unstructured":"Li Y, Zhu L, Hao R, Li Y, Zhao Q, Li S. Systematic expression analysis of the CELSR family reveals the importance of CELSR3 in human lung adenocarcinoma. J Cell Mol Med. 2021;25(9):4349\u201362. https:\/\/doi.org\/10.1111\/jcmm.16497.","journal-title":"J Cell Mol Med"},{"issue":"22","key":"327_CR69","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1016\/j.cub.2004.11.007","volume":"14","author":"PN Adler","year":"2004","unstructured":"Adler PN, Zhu C, Stone D. Inturned localizes to the proximal side of wing cells under the instruction of upstream planar polarity proteins. Curr Biol. 2004;14(22):2046\u201351. https:\/\/doi.org\/10.1016\/j.cub.2004.11.007.","journal-title":"Curr Biol"},{"issue":"6","key":"327_CR70","first-page":"1583","volume":"14","author":"M Katoh","year":"2005","unstructured":"Katoh M. WNT\/PCP signaling pathway and human cancer (review). Oncol Rep. 2005;14(6):1583\u20138.","journal-title":"Oncol Rep"},{"key":"327_CR71","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.actbio.2019.02.015","volume":"88","author":"Y Peng","year":"2019","unstructured":"Peng Y, Chen Z, Chen Y, Li S, Jiang Y, Yang H, et al. Rock isoforms differentially modulate cancer cell motility by mechanosensing the substrate stiffness. Acta Biomater. 2019;88:86\u2013101. https:\/\/doi.org\/10.1016\/j.actbio.2019.02.015.","journal-title":"Acta Biomater"},{"issue":"Pt 1","key":"327_CR72","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1042\/bj20050387","volume":"389","author":"CE Eyers","year":"2005","unstructured":"Eyers CE, McNeill H, Knebel A, Morrice N, Arthur SJ, Cuenda A, et al. The phosphorylation of CapZ-interacting protein (CapZIP) by stress-activated protein kinases triggers its dissociation from CapZ. Biochem J. 2005;389(Pt 1):127\u201335. https:\/\/doi.org\/10.1042\/bj20050387.","journal-title":"Biochem J"},{"issue":"7","key":"327_CR73","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.cell.2007.12.011","volume":"131","author":"MV Semenov","year":"2007","unstructured":"Semenov MV, Habas R, Macdonald BT, He X. SnapShot: Noncanonical Wnt Signaling Pathways. Cell. 2007;131(7):1378. https:\/\/doi.org\/10.1016\/j.cell.2007.12.011.","journal-title":"Cell"},{"issue":"4","key":"327_CR74","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1042\/bst20170519","volume":"46","author":"V Casado-Medrano","year":"2018","unstructured":"Casado-Medrano V, Baker MJ, Lopez-Haber C, Cooke M, Wang S, Caloca MJ, et al. The role of Rac in tumor susceptibility and disease progression: from biochemistry to the clinic. Biochem Soc Trans. 2018;46(4):1003\u201312. https:\/\/doi.org\/10.1042\/bst20170519.","journal-title":"Biochem Soc Trans"},{"issue":"22","key":"327_CR75","doi-asserted-by":"publisher","first-page":"7425","DOI":"10.1523\/jneurosci.5449-13.2014","volume":"34","author":"J Tang","year":"2014","unstructured":"Tang J, Ip JP, Ye T, Ng YP, Yung WH, Wu Z, et al. Cdk5-dependent Mst3 phosphorylation and activity regulate neuronal migration through RhoA inhibition. J Neurosci. 2014;34(22):7425\u201336. https:\/\/doi.org\/10.1523\/jneurosci.5449-13.2014.","journal-title":"J Neurosci"},{"issue":"3","key":"327_CR76","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/21541248.2016.1218407","volume":"9","author":"MF Olson","year":"2018","unstructured":"Olson MF. Rho GTPases, their post-translational modifications, disease-associated mutations and pharmacological inhibitors. Small GTPases. 2018;9(3):203\u201315. https:\/\/doi.org\/10.1080\/21541248.2016.1218407.","journal-title":"Small GTPases"},{"issue":"4","key":"327_CR77","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/ng.2916","volume":"46","author":"HY Yoo","year":"2014","unstructured":"Yoo HY, Sung MK, Lee SH, Kim S, Lee H, Park S, et al. A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma. Nat Genet. 2014;46(4):371\u20135. https:\/\/doi.org\/10.1038\/ng.2916.","journal-title":"Nat Genet"},{"issue":"8","key":"327_CR78","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/onc.2008.467","volume":"28","author":"C Fukukawa","year":"2009","unstructured":"Fukukawa C, Nagayama S, Tsunoda T, Toguchida J, Nakamura Y, Katagiri T. Activation of the non-canonical Dvl-Rac1-JNK pathway by Frizzled homologue 10 in human synovial sarcoma. Oncogene. 2009;28(8):1110\u201320. https:\/\/doi.org\/10.1038\/onc.2008.467.","journal-title":"Oncogene"},{"issue":"10","key":"327_CR79","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1093\/abbs\/gmr079","volume":"43","author":"AW De","year":"2011","unstructured":"De AW. Wnt\/Ca2+ signaling pathway: a brief overview. Acta Biochim Biophys Sin. 2011;43(10):745\u201356. https:\/\/doi.org\/10.1093\/abbs\/gmr079.","journal-title":"Acta Biochim Biophys Sin"},{"issue":"2","key":"327_CR80","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11912-019-0763-9","volume":"21","author":"J Harb","year":"2019","unstructured":"Harb J, Lin PJ, Hao J. Recent development of Wnt signaling pathway inhibitors for cancer therapeutics. Curr Oncol Rep. 2019;21(2):12. https:\/\/doi.org\/10.1007\/s11912-019-0763-9.","journal-title":"Curr Oncol Rep"},{"issue":"5","key":"327_CR81","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1111\/j.1471-4159.2007.04825.x","volume":"102","author":"K Mikoshiba","year":"2007","unstructured":"Mikoshiba K. IP3 receptor\/Ca2+ channel: from discovery to new signaling concepts. J Neurochem. 2007;102(5):1426\u201346. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.04825.x.","journal-title":"J Neurochem"},{"key":"327_CR82","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010555","author":"Z Zhao","year":"2025","unstructured":"Zhao Z, Hu Y, Li H, Lu T, He X, Ma Y, et al. Inhibition of stromal MAOA leading activation of WNT5A enhance prostate cancer immunotherapy by involving the transition of cancer-associated fibroblasts. J Immunother Cancer. 2025. https:\/\/doi.org\/10.1136\/jitc-2024-010555.","journal-title":"J Immunother Cancer"},{"issue":"6","key":"327_CR83","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.3892\/etm.2016.3885","volume":"12","author":"L Huang","year":"2016","unstructured":"Huang L, Jin Y, Feng S, Zou Y, Xu S, Qiu S, et al. Role of Wnt\/\u03b2-catenin, Wnt\/c-Jun N-terminal kinase and Wnt\/Ca(2+) pathways in cisplatin-induced chemoresistance in ovarian cancer. Exp Ther Med. 2016;12(6):3851\u20138. https:\/\/doi.org\/10.3892\/etm.2016.3885.","journal-title":"Exp Ther Med"},{"issue":"2","key":"327_CR84","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.yexcr.2018.02.004","volume":"364","author":"S Tian","year":"2018","unstructured":"Tian S, Hu J, Tao K, Wang J, Chu Y, Li J, et al. Secreted AGR2 promotes invasion of colorectal cancer cells via Wnt11-mediated non-canonical Wnt signaling. Exp Cell Res. 2018;364(2):198\u2013207. https:\/\/doi.org\/10.1016\/j.yexcr.2018.02.004.","journal-title":"Exp Cell Res"},{"issue":"5","key":"327_CR85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010456","volume":"5","author":"Q Wang","year":"2010","unstructured":"Wang Q, Symes AJ, Kane CA, Freeman A, Nariculam J, Munson P, et al. A novel role for Wnt\/Ca2+ signaling in actin cytoskeleton remodeling and cell motility in prostate cancer. PLoS ONE. 2010;5(5):e10456. https:\/\/doi.org\/10.1371\/journal.pone.0010456.","journal-title":"PLoS ONE"},{"issue":"12","key":"327_CR86","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/s41569-022-00718-5","volume":"19","author":"I Akoumianakis","year":"2022","unstructured":"Akoumianakis I, Polkinghorne M, Antoniades C. Non-canonical WNT signalling in cardiovascular disease: mechanisms and therapeutic implications. Nat Rev Cardiol. 2022;19(12):783\u201397. https:\/\/doi.org\/10.1038\/s41569-022-00718-5.","journal-title":"Nat Rev Cardiol"},{"key":"327_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2022.101149","volume":"95","author":"R Shah","year":"2023","unstructured":"Shah R, Amador C, Chun ST, Ghiam S, Saghizadeh M, Kramerov AA, et al. Non-canonical Wnt signaling in the eye. Prog Retin Eye Res. 2023;95:101149. https:\/\/doi.org\/10.1016\/j.preteyeres.2022.101149.","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"327_CR88","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","volume":"9","author":"Z Deng","year":"2024","unstructured":"Deng Z, Fan T, Xiao C, Tian H, Zheng Y, Li C, et al. TGF-\u03b2 signaling in health, disease, and therapeutics. Signal Transduct Target Ther. 2024;9(1):61. https:\/\/doi.org\/10.1038\/s41392-024-01764-w.","journal-title":"Signal Transduct Target Ther"},{"key":"327_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241210133","author":"Y Mitsui","year":"2023","unstructured":"Mitsui Y, Yamabe F, Hori S, Uetani M, Kobayashi H, Nagao K, et al. Molecular mechanisms and risk factors related to the pathogenesis of Peyronie\u2019s disease. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241210133.","journal-title":"Int J Mol Sci"},{"key":"327_CR90","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.696542","volume":"9","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Jin D, Kang X, Zhou R, Sun Y, Lian F, et al. Signaling pathways involved in diabetic renal fibrosis. Front Cell Dev Biol. 2021;9:696542. https:\/\/doi.org\/10.3389\/fcell.2021.696542.","journal-title":"Front Cell Dev Biol"},{"issue":"11","key":"327_CR91","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1091\/mbc.E10-12-1000","volume":"23","author":"M Ekman","year":"2012","unstructured":"Ekman M, Mu Y, Lee SY, Edlund S, Kozakai T, Thakur N, et al. APC and Smad7 link TGF\u03b2 type I receptors to the microtubule system to promote cell migration. Mol Biol Cell. 2012;23(11):2109\u201321. https:\/\/doi.org\/10.1091\/mbc.E10-12-1000.","journal-title":"Mol Biol Cell"},{"issue":"Pt 1","key":"327_CR92","first-page":"S31","volume":"83-A Suppl 1","author":"A Letamendia","year":"2001","unstructured":"Letamendia A, Labb\u00e9 E, Attisano L. Transcriptional regulation by Smads: crosstalk between the TGF-beta and Wnt pathways. J Bone Joint Surg Am. 2001;83-A Suppl 1(Pt 1):S31-9.","journal-title":"J Bone Joint Surg Am."},{"issue":"15","key":"327_CR93","doi-asserted-by":"publisher","first-page":"5132","DOI":"10.1128\/mcb.21.15.5132-5141.2001","volume":"21","author":"M Furuhashi","year":"2001","unstructured":"Furuhashi M, Yagi K, Yamamoto H, Furukawa Y, Shimada S, Nakamura Y, et al. Axin facilitates Smad3 activation in the transforming growth factor beta signaling pathway. Mol Cell Biol. 2001;21(15):5132\u201341. https:\/\/doi.org\/10.1128\/mcb.21.15.5132-5141.2001.","journal-title":"Mol Cell Biol"},{"key":"327_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/cells11223631","author":"P Sileo","year":"2022","unstructured":"Sileo P, Simonin C, Melnyk P, Chartier-Harlin MC, Cotelle P. Crosstalk between the hippo pathway and the Wnt pathway in Huntington\u2019s disease and other neurodegenerative disorders. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11223631.","journal-title":"Cells"},{"issue":"5","key":"327_CR95","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/emboj.2011.487","volume":"31","author":"M Imajo","year":"2012","unstructured":"Imajo M, Miyatake K, Iimura A, Miyamoto A, Nishida E. A molecular mechanism that links hippo signalling to the inhibition of Wnt\/\u03b2-catenin signalling. EMBO J. 2012;31(5):1109\u201322. https:\/\/doi.org\/10.1038\/emboj.2011.487.","journal-title":"EMBO J"},{"issue":"1","key":"327_CR96","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02391-x","volume":"24","author":"F Xie","year":"2025","unstructured":"Xie F, Lyu Y, Chen B, Leung HW, Yu P, Feng T, et al. STK3 is a transcriptional target of YAP1 and a hub component in the crosstalk between Hippo and Wnt signaling pathways during gastric carcinogenesis. Mol Cancer. 2025;24(1):186. https:\/\/doi.org\/10.1186\/s12943-025-02391-x.","journal-title":"Mol Cancer"},{"issue":"1","key":"327_CR97","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cell.2014.06.013","volume":"158","author":"L Azzolin","year":"2014","unstructured":"Azzolin L, Panciera T, Soligo S, Enzo E, Bicciato S, Dupont S, et al. YAP\/TAZ incorporation in the \u03b2-catenin destruction complex orchestrates the Wnt response. Cell. 2014;158(1):157\u201370. https:\/\/doi.org\/10.1016\/j.cell.2014.06.013.","journal-title":"Cell"},{"issue":"2","key":"327_CR98","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.molcel.2013.05.013","volume":"51","author":"J Wang","year":"2013","unstructured":"Wang J, Park JS, Wei Y, Rajurkar M, Cotton JL, Fan Q, et al. TRIB2 acts downstream of Wnt\/TCF in liver cancer cells to regulate YAP and C\/EBP\u03b1 function. Mol Cell. 2013;51(2):211\u201325. https:\/\/doi.org\/10.1016\/j.molcel.2013.05.013.","journal-title":"Mol Cell"},{"issue":"6","key":"327_CR99","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/cdd.2014.8","volume":"21","author":"MR Byun","year":"2014","unstructured":"Byun MR, Hwang JH, Kim AR, Kim KM, Hwang ES, Yaffe MB, et al. Canonical Wnt signalling activates TAZ through PP1A during osteogenic differentiation. Cell Death Differ. 2014;21(6):854\u201363. https:\/\/doi.org\/10.1038\/cdd.2014.8.","journal-title":"Cell Death Differ"},{"issue":"4","key":"327_CR100","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.cell.2015.07.013","volume":"162","author":"HW Park","year":"2015","unstructured":"Park HW, Kim YC, Yu B, Moroishi T, Mo JS, Plouffe SW, et al. Alternative Wnt signaling activates YAP\/TAZ. Cell. 2015;162(4):780\u201394. https:\/\/doi.org\/10.1016\/j.cell.2015.07.013.","journal-title":"Cell"},{"key":"327_CR101","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.semcancer.2021.04.003","volume":"85","author":"J Jiang","year":"2022","unstructured":"Jiang J. Hedgehog signaling mechanism and role in cancer. Semin Cancer Biol. 2022;85:107\u201322. https:\/\/doi.org\/10.1016\/j.semcancer.2021.04.003.","journal-title":"Semin Cancer Biol"},{"key":"327_CR102","doi-asserted-by":"publisher","unstructured":"Farahmand L, Darvishi B, Majidzadeh AK, Madjid Ansari A. Naturally occurring compounds acting as potent anti-metastatic agents and their suppressing effects on Hedgehog and WNT\/\u03b2-catenin signalling pathways. Cell Prolif. 2017;50(1). https:\/\/doi.org\/10.1111\/cpr.12299.","DOI":"10.1111\/cpr.12299"},{"issue":"47","key":"327_CR103","doi-asserted-by":"publisher","first-page":"35598","DOI":"10.1074\/jbc.C600200200","volume":"281","author":"J He","year":"2006","unstructured":"He J, Sheng T, Stelter AA, Li C, Zhang X, Sinha M, et al. Suppressing wnt signaling by the hedgehog pathway through sFRP-1. J Biol Chem. 2006;281(47):35598\u2013602. https:\/\/doi.org\/10.1074\/jbc.C600200200.","journal-title":"J Biol Chem"},{"issue":"1","key":"327_CR104","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1073\/pnas.0509927103","volume":"103","author":"B Wang","year":"2006","unstructured":"Wang B, Li Y. Evidence for the direct involvement of {beta}TrCP in Gli3 protein processing. Proc Natl Acad Sci U S A. 2006;103(1):33\u20138. https:\/\/doi.org\/10.1073\/pnas.0509927103.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7341","key":"327_CR105","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature09851","volume":"472","author":"K Shin","year":"2011","unstructured":"Shin K, Lee J, Guo N, Kim J, Lim A, Qu L, et al. Hedgehog\/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder. Nature. 2011;472(7341):110\u20134. https:\/\/doi.org\/10.1038\/nature09851.","journal-title":"Nature"},{"issue":"5","key":"327_CR106","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1172\/jci80205","volume":"126","author":"JS Rockel","year":"2016","unstructured":"Rockel JS, Yu C, Whetstone H, Craft AM, Reilly K, Ma H, et al. Hedgehog inhibits \u03b2-catenin activity in synovial joint development and osteoarthritis. J Clin Invest. 2016;126(5):1649\u201363. https:\/\/doi.org\/10.1172\/jci80205.","journal-title":"J Clin Invest"},{"issue":"3","key":"327_CR107","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.3390\/cancers7030867","volume":"7","author":"D Qualtrough","year":"2015","unstructured":"Qualtrough D, Rees P, Speight B, Williams AC, Paraskeva C. The hedgehog inhibitor cyclopamine reduces \u03b2-catenin-tcf transcriptional activity, induces E-cadherin expression, and reduces invasion in colorectal cancer cells. Cancers (Basel). 2015;7(3):1885\u201399. https:\/\/doi.org\/10.3390\/cancers7030867.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"327_CR108","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12964-024-01623-9","volume":"22","author":"DB Gumede","year":"2024","unstructured":"Gumede DB, Abrahamse H, Houreld NN. Targeting Wnt\/\u03b2-catenin signaling and its interplay with TGF-\u03b2 and Notch signaling pathways for the treatment of chronic wounds. Cell Commun Signal. 2024;22(1):244. https:\/\/doi.org\/10.1186\/s12964-024-01623-9.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"327_CR109","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1038\/s41467-018-06069-5","volume":"9","author":"M Mangolini","year":"2018","unstructured":"Mangolini M, G\u00f6tte F, Moore A, Ammon T, Oelsner M, Lutzny-Geier G, et al. Notch2 controls non-autonomous Wnt-signalling in chronic lymphocytic leukaemia. Nat Commun. 2018;9(1):3839. https:\/\/doi.org\/10.1038\/s41467-018-06069-5.","journal-title":"Nat Commun"},{"issue":"6","key":"327_CR110","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1158\/0008-5472.Can-12-3159","volume":"73","author":"J Camps","year":"2013","unstructured":"Camps J, Pitt JJ, Emons G, Hummon AB, Case CM, Grade M, et al. Genetic amplification of the NOTCH modulator LNX2 upregulates the WNT\/\u03b2-catenin pathway in colorectal cancer. Cancer Res. 2013;73(6):2003\u201313. https:\/\/doi.org\/10.1158\/0008-5472.Can-12-3159.","journal-title":"Cancer Res"},{"issue":"3","key":"327_CR111","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s13402-021-00591-3","volume":"44","author":"AP Patni","year":"2021","unstructured":"Patni AP, Harishankar MK, Joseph JP, Sreeshma B, Jayaraj R, Devi A. Comprehending the crosstalk between Notch, Wnt and Hedgehog signaling pathways in oral squamous cell carcinoma - clinical implications. Cell Oncol (Dordr). 2021;44(3):473\u201394. https:\/\/doi.org\/10.1007\/s13402-021-00591-3.","journal-title":"Cell Oncol (Dordr)"},{"issue":"22","key":"327_CR112","doi-asserted-by":"publisher","first-page":"4427","DOI":"10.1242\/dev.02644","volume":"133","author":"S Estrach","year":"2006","unstructured":"Estrach S, Ambler CA, Lo Celso C, Hozumi K, Watt FM. Jagged 1 is a beta-catenin target gene required for ectopic hair follicle formation in adult epidermis. Development. 2006;133(22):4427\u201338. https:\/\/doi.org\/10.1242\/dev.02644.","journal-title":"Development"},{"key":"327_CR113","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11010099","author":"SK Saha","year":"2019","unstructured":"Saha SK, Yin Y, Chae HS, Cho SG. Opposing regulation of cancer properties via KRT19-mediated differential modulation of Wnt\/\u03b2-catenin\/Notch signaling in breast and colon cancers. Cancers (Basel). 2019. https:\/\/doi.org\/10.3390\/cancers11010099.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"327_CR114","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/onc.2016.221","volume":"36","author":"SK Saha","year":"2017","unstructured":"Saha SK, Choi HY, Kim BW, Dayem AA, Yang GM, Kim KS, et al. KRT19 directly interacts with \u03b2-catenin\/RAC1 complex to regulate NUMB-dependent NOTCH signaling pathway and breast cancer properties. Oncogene. 2017;36(3):332\u201349. https:\/\/doi.org\/10.1038\/onc.2016.221.","journal-title":"Oncogene"},{"issue":"1","key":"327_CR115","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.stem.2013.04.012","volume":"13","author":"B Gu","year":"2013","unstructured":"Gu B, Watanabe K, Sun P, Fallahi M, Dai X. Chromatin effector Pygo2 mediates Wnt-notch crosstalk to suppress luminal\/alveolar potential of mammary stem and basal cells. Cell Stem Cell. 2013;13(1):48\u201361. https:\/\/doi.org\/10.1016\/j.stem.2013.04.012.","journal-title":"Cell Stem Cell"},{"issue":"44","key":"327_CR116","doi-asserted-by":"publisher","first-page":"36814","DOI":"10.1074\/jbc.M112.356048","volume":"287","author":"EJ Ann","year":"2012","unstructured":"Ann EJ, Kim HY, Seo MS, Mo JS, Kim MY, Yoon JH, et al. Wnt5a controls Notch1 signaling through CaMKII-mediated degradation of the SMRT corepressor protein. J Biol Chem. 2012;287(44):36814\u201329. https:\/\/doi.org\/10.1074\/jbc.M112.356048.","journal-title":"J Biol Chem"},{"issue":"45","key":"327_CR117","doi-asserted-by":"publisher","first-page":"42276","DOI":"10.1074\/jbc.M104227200","volume":"276","author":"C Lamberti","year":"2001","unstructured":"Lamberti C, Lin KM, Yamamoto Y, Verma U, Verma IM, Byers S, et al. Regulation of beta-catenin function by the IkappaB kinases. J Biol Chem. 2001;276(45):42276\u201386. https:\/\/doi.org\/10.1074\/jbc.M104227200.","journal-title":"J Biol Chem"},{"issue":"11","key":"327_CR118","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/j.cellsig.2006.02.014","volume":"18","author":"N Carayol","year":"2006","unstructured":"Carayol N, Wang CY. IKKalpha stabilizes cytosolic beta-catenin by inhibiting both canonical and non-canonical degradation pathways. Cell Signal. 2006;18(11):1941\u20136. https:\/\/doi.org\/10.1016\/j.cellsig.2006.02.014.","journal-title":"Cell Signal"},{"issue":"6","key":"327_CR119","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1093\/carcin\/bgs131","volume":"33","author":"FI Huang","year":"2012","unstructured":"Huang FI, Chen YL, Chang CN, Yuan RH, Jeng YM. Hepatocyte growth factor activates Wnt pathway by transcriptional activation of LEF1 to facilitate tumor invasion. Carcinogenesis. 2012;33(6):1142\u20138. https:\/\/doi.org\/10.1093\/carcin\/bgs131.","journal-title":"Carcinogenesis"},{"key":"327_CR120","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00378","volume":"7","author":"B Ma","year":"2016","unstructured":"Ma B, Hottiger MO. Crosstalk between Wnt\/\u03b2-catenin and NF-\u03bab signaling pathway during inflammation. Front Immunol. 2016;7:378. https:\/\/doi.org\/10.3389\/fimmu.2016.00378.","journal-title":"Front Immunol"},{"issue":"23","key":"327_CR121","doi-asserted-by":"publisher","first-page":"9469","DOI":"10.1073\/pnas.1300532110","volume":"110","author":"J Chang","year":"2013","unstructured":"Chang J, Liu F, Lee M, Wu B, Ting K, Zara JN, et al. NF-\u03baB inhibits osteogenic differentiation of mesenchymal stem cells by promoting \u03b2-catenin degradation. Proc Natl Acad Sci U S A. 2013;110(23):9469\u201374. https:\/\/doi.org\/10.1073\/pnas.1300532110.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"327_CR122","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.3390\/ijms15011647","volume":"15","author":"P Rishikaysh","year":"2014","unstructured":"Rishikaysh P, Dev K, Diaz D, Qureshi WM, Filip S, Mokry J. Signaling involved in hair follicle morphogenesis and development. Int J Mol Sci. 2014;15(1):1647\u201370. https:\/\/doi.org\/10.3390\/ijms15011647.","journal-title":"Int J Mol Sci"},{"issue":"37","key":"327_CR123","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1038\/onc.2008.141","volume":"27","author":"I Elcheva","year":"2008","unstructured":"Elcheva I, Tarapore RS, Bhatia N, Spiegelman VS. Overexpression of mRNA-binding protein CRD-BP in malignant melanomas. Oncogene. 2008;27(37):5069\u201374. https:\/\/doi.org\/10.1038\/onc.2008.141.","journal-title":"Oncogene"},{"issue":"8","key":"327_CR124","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.molmed.2012.06.008","volume":"18","author":"P Herr","year":"2012","unstructured":"Herr P, Hausmann G, Basler K. WNT secretion and signalling in human disease. Trends Mol Med. 2012;18(8):483\u201393. https:\/\/doi.org\/10.1016\/j.molmed.2012.06.008.","journal-title":"Trends Mol Med"},{"issue":"11","key":"327_CR125","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3002353","volume":"21","author":"A He","year":"2023","unstructured":"He A, Tian S, Kopper O, Horan DJ, Chen P, Bronson RT, et al. Targeted inhibition of Wnt signaling with a Clostridioides difficile toxin B fragment suppresses breast cancer tumor growth. PLoS Biol. 2023;21(11):e3002353. https:\/\/doi.org\/10.1371\/journal.pbio.3002353.","journal-title":"PLoS Biol"},{"issue":"11","key":"327_CR126","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1158\/1541-7786.Mcr-23-0334","volume":"22","author":"H Huang","year":"2024","unstructured":"Huang H, Jin H, Lei R, He Z, He S, Chen J, et al. LncRNA-WAL promotes triple-negative breast cancer aggression by inducing \u03b2-catenin nuclear translocation. Mol Cancer Res. 2024;22(11):1036\u201350. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-23-0334.","journal-title":"Mol Cancer Res"},{"key":"327_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216516","author":"W Zhong","year":"2024","unstructured":"Zhong W, Jian Y, Zhang C, Li Y, Yuan Z, Xiong Z, et al. Shc4 orchestrates \u03b2-catenin pathway-mediated metastasis in triple-negative breast cancer by promoting Src kinase autophosphorylation. Cancer Lett. 2024. https:\/\/doi.org\/10.1016\/j.canlet.2023.216516.","journal-title":"Cancer Lett"},{"issue":"12","key":"327_CR128","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06115-1","volume":"14","author":"W Tian","year":"2023","unstructured":"Tian W, Tang Y, Luo Y, Xie J, Zheng S, Zou Y, et al. Aurkaip1 actuates tumor progression through stabilizing DDX5 in triple negative breast cancer. Cell Death Dis. 2023;14(12):790. https:\/\/doi.org\/10.1038\/s41419-023-06115-1.","journal-title":"Cell Death Dis"},{"key":"327_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217179","volume":"600","author":"B Liu","year":"2024","unstructured":"Liu B, Liu Y, Yang S, Ye J, Hu J, Chen S, et al. Enhanced desmosome assembly driven by acquired high-level desmoglein-2 promotes phenotypic plasticity and endocrine resistance in ER(+) breast cancer. Cancer Lett. 2024;600:217179. https:\/\/doi.org\/10.1016\/j.canlet.2024.217179.","journal-title":"Cancer Lett"},{"issue":"1","key":"327_CR130","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-024-01394-2","volume":"15","author":"Y Huang","year":"2024","unstructured":"Huang Y, Fan M, Liu Y, Jiang X, Du K, Wu A, et al. Novel biomarkers and drug correlations of non-canonical WNT signaling in prostate and breast cancer. Discov Oncol. 2024;15(1):511. https:\/\/doi.org\/10.1007\/s12672-024-01394-2.","journal-title":"Discov Oncol"},{"key":"327_CR131","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2017.00135","volume":"7","author":"M Bayerlov\u00e1","year":"2017","unstructured":"Bayerlov\u00e1 M, Menck K, Klemm F, Wolff A, Pukrop T, Binder C, et al. Ror2 signaling and its relevance in breast cancer progression. Front Oncol. 2017;7:135. https:\/\/doi.org\/10.3389\/fonc.2017.00135.","journal-title":"Front Oncol"},{"issue":"2","key":"327_CR132","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13020259","volume":"13","author":"MR Makena","year":"2021","unstructured":"Makena MR, Ko M, Dang DK, Rao R. Epigenetic modulation of SPCA2 reverses epithelial to mesenchymal transition in breast cancer cells. Cancers (Basel). 2021;13(2):259. https:\/\/doi.org\/10.3390\/cancers13020259.","journal-title":"Cancers (Basel)"},{"issue":"6","key":"327_CR133","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020412","volume":"6","author":"S Siamakpour-Reihani","year":"2011","unstructured":"Siamakpour-Reihani S, Caster J, Bandhu Nepal D, Courtwright A, Hilliard E, Usary J, et al. The role of calcineurin\/NFAT in SFRP2 induced angiogenesis\u2013a rationale for breast cancer treatment with the calcineurin inhibitor tacrolimus. PLoS ONE. 2011;6(6):e20412. https:\/\/doi.org\/10.1371\/journal.pone.0020412.","journal-title":"PLoS ONE"},{"issue":"1","key":"327_CR134","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-68938-y","volume":"14","author":"M Ferrell","year":"2024","unstructured":"Ferrell M, Guven DC, Gomez CG, Nasrollahi E, Giza R, Cheng S, et al. Investigating the WNT and TGF-beta pathways alterations and tumor mutation burden in young-onset colorectal cancer. Sci Rep. 2024;14(1):17884. https:\/\/doi.org\/10.1038\/s41598-024-68938-y.","journal-title":"Sci Rep"},{"issue":"8028","key":"327_CR135","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41586-024-07769-3","volume":"633","author":"L Nunes","year":"2024","unstructured":"Nunes L, Li F, Wu M, Luo T, Hammarstr\u00f6m K, Torell E, et al. Prognostic genome and transcriptome signatures in colorectal cancers. Nature. 2024;633(8028):137\u201346. https:\/\/doi.org\/10.1038\/s41586-024-07769-3.","journal-title":"Nature"},{"issue":"1","key":"327_CR136","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-64149-7","volume":"14","author":"A Busico","year":"2024","unstructured":"Busico A, Gasparini P, Rausa E, Cattaneo L, Bozzi F, Silvestri M, et al. Molecular profiling of pediatric and young adult colorectal cancer reveals a distinct genomic landscapes and potential therapeutic avenues. Sci Rep. 2024;14(1):13138. https:\/\/doi.org\/10.1038\/s41598-024-64149-7.","journal-title":"Sci Rep"},{"issue":"2","key":"327_CR137","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/s0092-8674(00)81333-1","volume":"87","author":"KW Kinzler","year":"1996","unstructured":"Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 1996;87(2):159\u201370. https:\/\/doi.org\/10.1016\/s0092-8674(00)81333-1.","journal-title":"Cell"},{"issue":"1","key":"327_CR138","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-59899-z","volume":"10","author":"TW Parker","year":"2020","unstructured":"Parker TW, Neufeld KL. APC controls Wnt-induced \u03b2-catenin destruction complex recruitment in human colonocytes. Sci Rep. 2020;10(1):2957. https:\/\/doi.org\/10.1038\/s41598-020-59899-z.","journal-title":"Sci Rep"},{"key":"327_CR139","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202012112","author":"J Nong","year":"2021","unstructured":"Nong J, Kang K, Shi Q, Zhu X, Tao Q, Chen YG. Phase separation of Axin organizes the \u03b2-catenin destruction complex. J Cell Biol. 2021. https:\/\/doi.org\/10.1083\/jcb.202012112.","journal-title":"J Cell Biol"},{"issue":"1","key":"327_CR140","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-023-05068-0","volume":"81","author":"D Zhang","year":"2024","unstructured":"Zhang D, Ni QQ, Wang SY, He WF, Hong ZX, Liu HY, et al. APC mutations disrupt \u03b2-catenin destruction complex condensates organized by Axin phase separation. Cell Mol Life Sci. 2024;81(1):57. https:\/\/doi.org\/10.1007\/s00018-023-05068-0.","journal-title":"Cell Mol Life Sci"},{"issue":"50","key":"327_CR141","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1038\/s41388-024-03141-x","volume":"43","author":"M Reissland","year":"2024","unstructured":"Reissland M, Hartmann O, Tauch S, Bugter JM, Prieto-Garcia C, Schulte C, et al. USP10 drives cancer stemness and enables super-competitor signalling in colorectal cancer. Oncogene. 2024;43(50):3645\u201359. https:\/\/doi.org\/10.1038\/s41388-024-03141-x.","journal-title":"Oncogene"},{"key":"327_CR142","doi-asserted-by":"publisher","DOI":"10.1172\/jci184442","author":"LZ Luo","year":"2025","unstructured":"Luo LZ, Kim JH, Herrera I, Wu S, Wu X, Park SS, et al. HMGA1 acts as an epigenetic gatekeeper of ASCL2 and Wnt signaling during colon tumorigenesis. J Clin Invest. 2025. https:\/\/doi.org\/10.1172\/jci184442.","journal-title":"J Clin Invest"},{"issue":"1","key":"327_CR143","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41416-023-02484-8","volume":"130","author":"M Chen","year":"2024","unstructured":"Chen M, Mashima T, Oishi T, Muramatsu Y, Seto Y, Takamatsu M, et al. APC\/PIK3CA mutations and \u03b2-catenin status predict tankyrase inhibitor sensitivity of patient-derived colorectal cancer cells. Br J Cancer. 2024;130(1):151\u201362. https:\/\/doi.org\/10.1038\/s41416-023-02484-8.","journal-title":"Br J Cancer"},{"issue":"1","key":"327_CR144","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1186\/s12967-024-05305-5","volume":"22","author":"FJ Di Paola","year":"2024","unstructured":"Di Paola FJ, Alquati C, Conti G, Calafato G, Turroni S, D\u2019Amico F, et al. Interplay between WNT\/PI3K-mTOR axis and the microbiota in APC-driven colorectal carcinogenesis: data from a pilot study and possible implications for CRC prevention. J Transl Med. 2024;22(1):631. https:\/\/doi.org\/10.1186\/s12967-024-05305-5.","journal-title":"J Transl Med"},{"issue":"4","key":"327_CR145","doi-asserted-by":"publisher","first-page":"5037","DOI":"10.3892\/mmr.2018.8533","volume":"17","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Wang Y, Zhang J, Zhong J, Yang R. COL1A1 promotes metastasis in colorectal cancer by regulating the WNT\/PCP pathway. Mol Med Rep. 2018;17(4):5037\u201342. https:\/\/doi.org\/10.3892\/mmr.2018.8533.","journal-title":"Mol Med Rep"},{"issue":"4","key":"327_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2023.11.008","volume":"14","author":"H Sui","year":"2024","unstructured":"Sui H, Deng W, Chai Q, Han B, Zhang Y, Wei Z, et al. YTE-17 inhibits colonic carcinogenesis by resetting antitumor immune response via Wnt5a\/JNK mediated metabolic signaling. J Pharm Anal. 2024;14(4):100901. https:\/\/doi.org\/10.1016\/j.jpha.2023.11.008.","journal-title":"J Pharm Anal"},{"issue":"28","key":"327_CR147","doi-asserted-by":"publisher","first-page":"4060","DOI":"10.1038\/onc.2017.16","volume":"36","author":"X Ma","year":"2017","unstructured":"Ma X, Meng Z, Jin L, Xiao Z, Wang X, Tsark WM, et al. CAMK2\u03b3 in intestinal epithelial cells modulates colitis-associated colorectal carcinogenesis via enhancing STAT3 activation. Oncogene. 2017;36(28):4060\u201371. https:\/\/doi.org\/10.1038\/onc.2017.16.","journal-title":"Oncogene"},{"issue":"9","key":"327_CR148","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1248\/bpb.b22-00053","volume":"45","author":"L Hu","year":"2022","unstructured":"Hu L, Dong H, He L, Shi M, Xiang N, Su Y, et al. Evacetrapib elicits antitumor effects on colorectal cancer by inhibiting the Wnt\/\u03b2-catenin signaling pathway and activating the JNK signaling pathway. Biol Pharm Bull. 2022;45(9):1238\u201345. https:\/\/doi.org\/10.1248\/bpb.b22-00053.","journal-title":"Biol Pharm Bull"},{"key":"327_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrrev.2023.108465","volume":"792","author":"M Tufail","year":"2023","unstructured":"Tufail M, Wu C. WNT5A: a double-edged sword in colorectal cancer progression. Mutat Res. 2023;792:108465. https:\/\/doi.org\/10.1016\/j.mrrev.2023.108465.","journal-title":"Mutat Res"},{"key":"327_CR150","doi-asserted-by":"publisher","DOI":"10.3390\/cells13242035","author":"CM Wu","year":"2024","unstructured":"Wu CM, Chen CH, Tsai KW, Tan MC, Tsai FY, Jiang SS, et al. TCF12 and LncRNA MALAT1 cooperatively harness high cyclin D1 but low \u03b2-catenin gene expression to exacerbate colorectal cancer prognosis independently of metastasis. Cells. 2024. https:\/\/doi.org\/10.3390\/cells13242035.","journal-title":"Cells"},{"issue":"1","key":"327_CR151","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-024-01563-4","volume":"17","author":"P Song","year":"2024","unstructured":"Song P, Gao Z, Bao Y, Chen L, Huang Y, Liu Y, et al. Wnt\/\u03b2-catenin signaling pathway in carcinogenesis and cancer therapy. J Hematol Oncol. 2024;17(1):46. https:\/\/doi.org\/10.1186\/s13045-024-01563-4.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"327_CR152","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02642-z","volume":"42","author":"S Xu","year":"2023","unstructured":"Xu S, Luo C, Chen D, Tang L, Cheng Q, Chen L, et al. CircMMD reduction following tumor treating fields inhibits glioblastoma progression through FUBP1\/FIR\/DVL1 and miR-15b-5p\/FZD6 signaling. J Exp Clin Cancer Res. 2023;42(1):64. https:\/\/doi.org\/10.1186\/s13046-023-02642-z.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"327_CR153","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-024-03038-3","volume":"43","author":"P Yu","year":"2024","unstructured":"Yu P, Xu T, Ma W, Fang X, Bao Y, Xu C, et al. PRMT6-mediated transcriptional activation of ythdf2 promotes glioblastoma migration, invasion, and emt via the wnt-\u03b2-catenin pathway. J Exp Clin Cancer Res. 2024;43(1):116. https:\/\/doi.org\/10.1186\/s13046-024-03038-3.","journal-title":"J Exp Clin Cancer Res"},{"key":"327_CR154","doi-asserted-by":"publisher","DOI":"10.2147\/dddt.S405450","volume":"17","author":"Y Wang","year":"2023","unstructured":"Wang Y, Gao G, Wei X, Zhang Y, Yu J. Ube2t promotes temozolomide resistance of glioblastoma through regulating the Wnt\/\u03b2-catenin signaling pathway. Drug Des Devel Ther. 2023;17:1357\u20131369. https:\/\/doi.org\/10.2147\/dddt.S405450.","journal-title":"Drug Des Devel Ther"},{"issue":"6","key":"327_CR155","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/acn3.51743","volume":"10","author":"Y Li","year":"2023","unstructured":"Li Y, Zheng X, Wang J, Sun M, Li D, Wang Z, et al. Exosomal circ-AHCY promotes glioblastoma cell growth via Wnt\/\u03b2-catenin signaling pathway. Ann Clin Transl Neurol. 2023;10(6):865\u201378. https:\/\/doi.org\/10.1002\/acn3.51743.","journal-title":"Ann Clin Transl Neurol"},{"issue":"7","key":"327_CR156","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05967-x","volume":"14","author":"EJ Yun","year":"2023","unstructured":"Yun EJ, Kim D, Kim S, Hsieh JT, Baek ST. Targeting Wnt\/\u03b2-catenin-mediated upregulation of oncogenic NLGN3 suppresses cancer stem cells in glioblastoma. Cell Death Dis. 2023;14(7):423. https:\/\/doi.org\/10.1038\/s41419-023-05967-x.","journal-title":"Cell Death Dis"},{"key":"327_CR157","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay7522","author":"M Huang","year":"2020","unstructured":"Huang M, Zhang D, Wu JY, Xing K, Yeo E, Li C, et al. Wnt-mediated endothelial transformation into mesenchymal stem cell-like cells induces chemoresistance in glioblastoma. Sci Transl Med. 2020. https:\/\/doi.org\/10.1126\/scitranslmed.aay7522.","journal-title":"Sci Transl Med"},{"key":"327_CR158","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2021.147500","volume":"1765","author":"C Li","year":"2021","unstructured":"Li C, Yang J, Lei S, Wang W. Ska3 promotes glioblastoma proliferation and invasion by enhancing the activation of Wnt\/\u03b2-catenin signaling via modulation of the Akt\/GSK-3\u03b2 axis. Brain Res. 2021;1765:147500. https:\/\/doi.org\/10.1016\/j.brainres.2021.147500.","journal-title":"Brain Res"},{"key":"327_CR159","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/bs.irn.2020.03.006","volume":"151","author":"V Shevchenko","year":"2020","unstructured":"Shevchenko V, Arnotskaya N, Zaitsev S, Sharma A, Sharma HS, Bryukhovetskiy A, et al. Proteins of Wnt signaling pathway in cancer stem cells of human glioblastoma. Int Rev Neurobiol. 2020;151:185\u2013200. https:\/\/doi.org\/10.1016\/bs.irn.2020.03.006.","journal-title":"Int Rev Neurobiol."},{"issue":"10","key":"327_CR160","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1242\/dev.054080","volume":"138","author":"LV Goodrich","year":"2011","unstructured":"Goodrich LV, Strutt D. Principles of planar polarity in animal development. Development. 2011;138(10):1877\u201392. https:\/\/doi.org\/10.1242\/dev.054080.","journal-title":"Development"},{"key":"327_CR161","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216280","volume":"567","author":"CA Dreyer","year":"2023","unstructured":"Dreyer CA, VanderVorst K, Natwick D, Bell G, Sood P, Hernandez M, et al. A complex of Wnt\/planar cell polarity signaling components Vangl1 and Fzd7 drives glioblastoma multiforme malignant properties. Cancer Lett. 2023;567:216280. https:\/\/doi.org\/10.1016\/j.canlet.2023.216280.","journal-title":"Cancer Lett"},{"key":"327_CR162","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1527226","volume":"14","author":"M Zhao","year":"2024","unstructured":"Zhao M, Chen S. The role of VANGL2 in glioma oncogenesis and progression: insights into expression profiles and prognostic relevance. Front Oncol. 2024;14:1527226. https:\/\/doi.org\/10.3389\/fonc.2024.1527226.","journal-title":"Front Oncol"},{"key":"327_CR163","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12885","volume":"7","author":"T Huang","year":"2016","unstructured":"Huang T, Alvarez AA, Pangeni RP, Horbinski CM, Lu S, Kim SH, et al. A regulatory circuit of miR-125b\/miR-20b and Wnt signalling controls glioblastoma phenotypes through FZD6-modulated pathways. Nat Commun. 2016;7:12885. https:\/\/doi.org\/10.1038\/ncomms12885.","journal-title":"Nat Commun"},{"key":"327_CR164","doi-asserted-by":"publisher","DOI":"10.1177\/10732748241293680","volume":"31","author":"YA Idrissi","year":"2024","unstructured":"Idrissi YA, Rajabi MR, Beumer JH, Monga SP, Saeed A. Exploring the impact of the \u03b2-catenin mutations in hepatocellular carcinoma: an in-depth review. Cancer Control. 2024;31:10732748241293680. https:\/\/doi.org\/10.1177\/10732748241293680.","journal-title":"Cancer Control"},{"issue":"4","key":"327_CR165","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/his.15363","volume":"86","author":"YJ Hwang","year":"2025","unstructured":"Hwang YJ, Lee Y, Yu SJ, Hong SK, Yi NJ, Choi Y, et al. Correlation between CTNNB1 mutation status and tumour phenotype in hepatitis B virus-related hepatocellular carcinoma. Histopathology. 2025;86(4):547\u201358. https:\/\/doi.org\/10.1111\/his.15363.","journal-title":"Histopathology"},{"issue":"12","key":"327_CR166","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1038\/s41416-024-02849-7","volume":"131","author":"C Dantzer","year":"2024","unstructured":"Dantzer C, Dif L, Vach\u00e9 J, Basbous S, Billottet C, Moreau V. Specific features of \u00df-catenin-mutated hepatocellular carcinomas. Br J Cancer. 2024;131(12):1871\u201380. https:\/\/doi.org\/10.1038\/s41416-024-02849-7.","journal-title":"Br J Cancer"},{"issue":"1","key":"327_CR167","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jhep.2021.01.044","volume":"75","author":"B Liang","year":"2021","unstructured":"Liang B, Zhou Y, Qian M, Xu M, Wang J, Zhang Y, et al. TBX3 functions as a tumor suppressor downstream of activated CTNNB1 mutants during hepatocarcinogenesis. J Hepatol. 2021;75(1):120\u201331. https:\/\/doi.org\/10.1016\/j.jhep.2021.01.044.","journal-title":"J Hepatol"},{"issue":"52","key":"327_CR168","doi-asserted-by":"publisher","first-page":"86985","DOI":"10.18632\/oncotarget.13521","volume":"7","author":"UJ Lemberger","year":"2016","unstructured":"Lemberger UJ, Fuchs CD, Karer M, Haas S, Stojakovic T, Sch\u00f6fer C, et al. Hepatocyte specific expression of an oncogenic variant of \u03b2-catenin results in cholestatic liver disease. Oncotarget. 2016;7(52):86985\u201398. https:\/\/doi.org\/10.18632\/oncotarget.13521.","journal-title":"Oncotarget"},{"key":"327_CR169","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216690","volume":"586","author":"K Wang","year":"2024","unstructured":"Wang K, Wu J, Yang Z, Zheng B, Shen S, Wang RR, et al. Hyperactivation of \u03b2-catenin signal in hepatocellular carcinoma recruits myeloid-derived suppressor cells through PF4-CXCR3 axis. Cancer Lett. 2024;586:216690. https:\/\/doi.org\/10.1016\/j.canlet.2024.216690.","journal-title":"Cancer Lett"},{"key":"327_CR170","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.123240","volume":"359","author":"Y Gu","year":"2024","unstructured":"Gu Y, Wang Z, Liang G, Peng J, Zhang X, Yu T, et al. Sirt7 stabilizes \u03b2-catenin and promotes canonical Wnt activation via upregulating FZD7. Life Sci. 2024;359:123240. https:\/\/doi.org\/10.1016\/j.lfs.2024.123240.","journal-title":"Life Sci"},{"issue":"32","key":"327_CR171","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1038\/s41388-023-02767-7","volume":"42","author":"X Zhang","year":"2023","unstructured":"Zhang X, Wu N, Huang H, Li S, Liu S, Zhang R, et al. Phosphorylated PTTG1 switches its subcellular distribution and promotes \u03b2-catenin stabilization and subsequent transcription activity. Oncogene. 2023;42(32):2439\u201355. https:\/\/doi.org\/10.1038\/s41388-023-02767-7.","journal-title":"Oncogene"},{"issue":"9","key":"327_CR172","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.31344","volume":"239","author":"Z Su","year":"2024","unstructured":"Su Z, Lu C, Zhang F, Liu H, Li M, Qiao M, et al. Cancer-associated fibroblasts-secreted exosomal miR-92a-3p promotes tumor growth and stemness in hepatocellular carcinoma through activation of Wnt\/\u03b2-catenin signaling pathway by suppressing AXIN1. J Cell Physiol. 2024;239(9):e31344. https:\/\/doi.org\/10.1002\/jcp.31344.","journal-title":"J Cell Physiol"},{"key":"327_CR173","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021417","author":"KS Jeng","year":"2023","unstructured":"Jeng KS, Chang CF, Sheen IS, Jeng CJ, Wang CH. Cellular and molecular biology of cancer stem cells of hepatocellular carcinoma. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24021417.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"327_CR174","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3748\/wjg.v18.i12.1328","volume":"18","author":"M Geng","year":"2012","unstructured":"Geng M, Cao YC, Chen YJ, Jiang H, Bi LQ, Liu XH. Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis. World J Gastroenterol. 2012;18(12):1328\u201338. https:\/\/doi.org\/10.3748\/wjg.v18.i12.1328.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"327_CR175","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1245\/s10434-023-14402-6","volume":"31","author":"K Wakizaka","year":"2024","unstructured":"Wakizaka K, Kamiyama T, Kakisaka T, Orimo T, Nagatsu A, Aiyama T, et al. Expression of Wnt5a and ROR2, components of the noncanonical Wnt-signaling pathway, is associated with tumor differentiation in hepatocellular carcinoma. Ann Surg Oncol. 2024;31(1):262\u201371. https:\/\/doi.org\/10.1245\/s10434-023-14402-6.","journal-title":"Ann Surg Oncol"},{"key":"327_CR176","doi-asserted-by":"publisher","unstructured":"Huang FY, Wong DK, Mak LY, Cheung TT, Zhang SS, Chau HT, et al. FAT4 loss initiates hepatocarcinogenesis through the switching of canonical to noncanonical WNT signaling pathways. Hepatol Commun. 2023;7(12). https:\/\/doi.org\/10.1097\/hc9.0000000000000338.","DOI":"10.1097\/hc9.0000000000000338"},{"issue":"2","key":"327_CR177","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.gendis.2020.07.009","volume":"8","author":"Y Liu","year":"2021","unstructured":"Liu Y, Deng H, Liang L, Zhang G, Xia J, Ding K, et al. Depletion of VPS35 attenuates metastasis of hepatocellular carcinoma by restraining the Wnt\/PCP signaling pathway. Genes Dis. 2021;8(2):232\u201340. https:\/\/doi.org\/10.1016\/j.gendis.2020.07.009.","journal-title":"Genes Dis"},{"issue":"5","key":"327_CR178","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.3892\/ijo.2017.3937","volume":"50","author":"T Asano","year":"2017","unstructured":"Asano T, Yamada S, Fuchs BC, Takami H, Hayashi M, Sugimoto H, et al. Clinical implication of Frizzled 2 expression and its association with epithelial-to-mesenchymal transition in hepatocellular carcinoma. Int J Oncol. 2017;50(5):1647\u201354. https:\/\/doi.org\/10.3892\/ijo.2017.3937.","journal-title":"Int J Oncol"},{"issue":"23","key":"327_CR179","doi-asserted-by":"publisher","first-page":"9918","DOI":"10.1158\/0008-5472.Can-08-1718","volume":"68","author":"G Wang","year":"2008","unstructured":"Wang G, Wang J, Sadar MD. Crosstalk between the androgen receptor and beta-catenin in castrate-resistant prostate cancer. Cancer Res. 2008;68(23):9918\u201327. https:\/\/doi.org\/10.1158\/0008-5472.Can-08-1718.","journal-title":"Cancer Res"},{"issue":"9","key":"327_CR180","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1002\/mc.23565","volume":"62","author":"IM Atawia","year":"2023","unstructured":"Atawia IM, Kushwaha PP, Verma S, Lin S, Shankar E, Abdel-Gawad O, et al. Inhibition of Wnt\/\u03b2-catenin pathway overcomes therapeutic resistance to abiraterone in castration-resistant prostate cancer. Mol Carcinog. 2023;62(9):1312\u201324. https:\/\/doi.org\/10.1002\/mc.23565.","journal-title":"Mol Carcinog"},{"issue":"2","key":"327_CR181","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s41391-024-00869-1","volume":"28","author":"A Broderick","year":"2025","unstructured":"Broderick A, Pan E, Li J, Chu A, Hwang C, Barata PC, et al. Clinical implications of Wnt pathway genetic alterations in men with advanced prostate cancer. Prostate Cancer Prostatic Dis. 2025;28(2):419\u201326. https:\/\/doi.org\/10.1038\/s41391-024-00869-1.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"327_CR182","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1186\/s12935-020-01624-x","volume":"20","author":"W Li","year":"2020","unstructured":"Li W, Yang G, Yang D, Li D, Sun Q. LncRNA LEF1-AS1 promotes metastasis of prostatic carcinoma via the Wnt\/\u03b2-catenin pathway. Cancer Cell Int. 2020;20(1):543. https:\/\/doi.org\/10.1186\/s12935-020-01624-x.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"327_CR183","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13062-024-00469-y","volume":"19","author":"B Yang","year":"2024","unstructured":"Yang B, Chen W, Tao T, Zhang J, Kong D, Hao J, et al. Ube2n promotes cell viability and glycolysis by promoting Axin1 ubiquitination in prostate cancer cells. Biol Direct. 2024;19(1):35. https:\/\/doi.org\/10.1186\/s13062-024-00469-y.","journal-title":"Biol Direct"},{"key":"327_CR184","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2021.110015","volume":"84","author":"S Wu","year":"2021","unstructured":"Wu S, Yue Y, Gu Y, Wang Q, Liu T, Li L, et al. MUC15 loss facilitates epithelial-mesenchymal transition and cancer stemness for prostate cancer metastasis through GSK3\u03b2\/\u03b2-catenin signaling. Cell Signal. 2021;84:110015. https:\/\/doi.org\/10.1016\/j.cellsig.2021.110015.","journal-title":"Cell Signal"},{"issue":"33","key":"327_CR185","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2402903121","volume":"121","author":"G Yu","year":"2024","unstructured":"Yu G, Corn PG, Mak CSL, Liang X, Zhang M, Troncoso P, et al. Prostate cancer-induced endothelial-cell-to-osteoblast transition drives immunosuppression in the bone-tumor microenvironment through Wnt pathway-induced M2 macrophage polarization. Proc Natl Acad Sci U S A. 2024;121(33):e2402903121. https:\/\/doi.org\/10.1073\/pnas.2402903121.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"327_CR186","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-019-0410-y","volume":"17","author":"D Nath","year":"2019","unstructured":"Nath D, Li X, Mondragon C, Post D, Chen M, White JR, et al. Abi1 loss drives prostate tumorigenesis through activation of EMT and non-canonical WNT signaling. Cell Commun Signal. 2019;17(1):120. https:\/\/doi.org\/10.1186\/s12964-019-0410-y.","journal-title":"Cell Commun Signal"},{"issue":"10","key":"327_CR187","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1422","volume":"13","author":"RJ Liu","year":"2023","unstructured":"Liu RJ, Xu ZP, Huang X, Xu B, Chen M. Yin Yang 1 promotes the neuroendocrine differentiation of prostate cancer cells via the non-canonical WNT pathway (FYN\/STAT3). Clin Transl Med. 2023;13(10):e1422. https:\/\/doi.org\/10.1002\/ctm2.1422.","journal-title":"Clin Transl Med"},{"issue":"6","key":"327_CR188","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0234078","volume":"15","author":"SR Sennoune","year":"2020","unstructured":"Sennoune SR, Nelius T, Jarvis C, Pruitt K, Kottapalli KR, Filleur S. The Wnt non-canonical signaling modulates cabazitaxel sensitivity in prostate cancer cells. PLoS ONE. 2020;15(6):e0234078. https:\/\/doi.org\/10.1371\/journal.pone.0234078.","journal-title":"PLoS ONE"},{"issue":"8","key":"327_CR189","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1158\/0008-5472.Can-21-1807","volume":"82","author":"F Ma","year":"2022","unstructured":"Ma F, Arai S, Wang K, Calagua C, Yuan AR, Poluben L, et al. Autocrine canonical Wnt signaling primes noncanonical signaling through ROR1 in metastatic castration-resistant prostate cancer. Cancer Res. 2022;82(8):1518\u201333. https:\/\/doi.org\/10.1158\/0008-5472.Can-21-1807.","journal-title":"Cancer Res"},{"key":"327_CR190","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713179","author":"F Lasorsa","year":"2023","unstructured":"Lasorsa F, Rutigliano M, Milella M, Ferro M, Pandolfo SD, Crocetto F, et al. Cancer stem cells in renal cell carcinoma: origins and biomarkers. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241713179.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"327_CR191","doi-asserted-by":"publisher","first-page":"7782","DOI":"10.1021\/acsomega.3c07265","volume":"9","author":"K Zhong","year":"2024","unstructured":"Zhong K, Wang X, Zhang H, Chen N, Mai Y, Dai S, et al. BIRC6 Modulates the Protein Stability of Axin to Regulate the Growth, Stemness, and Resistance of Renal Cancer Cells via the \u03b2-Catenin Pathway. ACS Omega. 2024;9(7):7782\u201392. https:\/\/doi.org\/10.1021\/acsomega.3c07265.","journal-title":"ACS Omega"},{"issue":"1","key":"327_CR192","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4149\/neo_2019_190217N135","volume":"67","author":"XG Chi","year":"2020","unstructured":"Chi XG, Meng XX, Ding DL, Xuan XH, Chen YZ, Cai Q, et al. HMGA1-mediated miR-671-5p targets APC to promote metastasis of clear cell renal cell carcinoma through Wnt signaling. Neoplasma. 2020;67(1):46\u201353. https:\/\/doi.org\/10.4149\/neo_2019_190217N135.","journal-title":"Neoplasma"},{"issue":"1","key":"327_CR193","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00018-024-05504-9","volume":"81","author":"Y Huang","year":"2024","unstructured":"Huang Y, Wen Z, Tao S, Yu Z, Wang X, Li X, et al. CLIP170 enhancing FOSL1 expression via attenuating ubiquitin-mediated degradation of \u03b2-catenin drives renal cell carcinoma progression. Cell Mol Life Sci. 2024;81(1):467. https:\/\/doi.org\/10.1007\/s00018-024-05504-9.","journal-title":"Cell Mol Life Sci"},{"key":"327_CR194","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110938","volume":"113","author":"N Wronski","year":"2024","unstructured":"Wronski N, Madej E, Grabacka M, Bro\u017cyna AA, Wolnicka-Glubisz A. RIPK4 downregulation impairs Wnt3A-stimulated invasiveness via Wnt\/\u03b2-catenin signaling in melanoma cells and tumor growth in vivo. Cell Signal. 2024;113:110938. https:\/\/doi.org\/10.1016\/j.cellsig.2023.110938.","journal-title":"Cell Signal"},{"issue":"18","key":"327_CR195","doi-asserted-by":"publisher","first-page":"5825","DOI":"10.1158\/1078-0432.Ccr-07-5104","volume":"14","author":"PD Da Forno","year":"2008","unstructured":"Da Forno PD, Pringle JH, Hutchinson P, Osborn J, Huang Q, Potter L, et al. WNT5A expression increases during melanoma progression and correlates with outcome. Clin Cancer Res. 2008;14(18):5825\u201332. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-07-5104.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"327_CR196","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/s1535-6108(02)00045-4","volume":"1","author":"AT Weeraratna","year":"2002","unstructured":"Weeraratna AT, Jiang Y, Hostetter G, Rosenblatt K, Duray P, Bittner M, et al. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell. 2002;1(3):279\u201388. https:\/\/doi.org\/10.1016\/s1535-6108(02)00045-4.","journal-title":"Cancer Cell"},{"issue":"10","key":"327_CR197","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1002\/1878-0261.13660","volume":"18","author":"J Wohlfarth","year":"2024","unstructured":"Wohlfarth J, Kosnopfel C, Faber D, Berthold M, Siedel C, Bernhardt M, et al. Loss of p14 diminishes immunogenicity in melanoma via non-canonical Wnt signaling by reducing the peptide surface density. Mol Oncol. 2024;18(10):2449\u201370. https:\/\/doi.org\/10.1002\/1878-0261.13660.","journal-title":"Mol Oncol"},{"issue":"10","key":"327_CR198","doi-asserted-by":"publisher","first-page":"4548","DOI":"10.1073\/pnas.1813802116","volume":"116","author":"C Li","year":"2019","unstructured":"Li C, Nguyen V, Clark KN, Zahed T, Sharkas S, Filipp FV, et al. Down-regulation of FZD3 receptor suppresses growth and metastasis of human melanoma independently of canonical WNT signaling. Proc Natl Acad Sci USA. 2019;116(10):4548\u201357. https:\/\/doi.org\/10.1073\/pnas.1813802116.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"327_CR199","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.jid.2022.09.658","volume":"143","author":"B Dong","year":"2023","unstructured":"Dong B, Simonson L, Vold S, Oldham E, Barten L, Ahmad N, et al. FZD6 promotes melanoma cell invasion but not proliferation by regulating canonical Wnt signaling and epithelial-mesenchymal transition. J Invest Dermatol. 2023;143(4):621-629.e6. https:\/\/doi.org\/10.1016\/j.jid.2022.09.658.","journal-title":"J Invest Dermatol"},{"key":"327_CR200","doi-asserted-by":"publisher","first-page":"1456959","DOI":"10.3389\/fonc.2024.1456959","volume":"14","author":"Y Ding","year":"2024","unstructured":"Ding Y, Chen Q. Wnt\/\u03b2-catenin signaling pathway: an attractive potential therapeutic target in osteosarcoma. Front Oncol. 2024;14:1456959. https:\/\/doi.org\/10.3389\/fonc.2024.1456959.","journal-title":"Front Oncol."},{"key":"327_CR201","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/978-3-030-43085-6_8","volume":"1258","author":"A Singla","year":"2020","unstructured":"Singla A, Wang J, Yang R, Geller DS, Loeb DM, Hoang BH. Wnt Signaling in Osteosarcoma. Adv Exp Med Biol. 2020;1258:125\u201339. https:\/\/doi.org\/10.1007\/978-3-030-43085-6_8.","journal-title":"Adv Exp Med Biol."},{"issue":"7","key":"327_CR202","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1172\/jci88620","volume":"126","author":"D Bhavanasi","year":"2016","unstructured":"Bhavanasi D, Speer KF, Klein PS. CKAP4 is identified as a receptor for Dickkopf in cancer cells. J Clin Invest. 2016;126(7):2419\u201321. https:\/\/doi.org\/10.1172\/jci88620.","journal-title":"J Clin Invest"},{"issue":"2","key":"327_CR203","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.67","volume":"5","author":"U Krause","year":"2014","unstructured":"Krause U, Ryan DM, Clough BH, Gregory CA. An unexpected role for a Wnt-inhibitor: Dickkopf-1 triggers a novel cancer survival mechanism through modulation of aldehyde-dehydrogenase-1 activity. Cell Death Dis. 2014;5(2):e1093. https:\/\/doi.org\/10.1038\/cddis.2014.67.","journal-title":"Cell Death Dis"},{"issue":"11","key":"327_CR204","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1177\/0022034517717478","volume":"96","author":"J Wang","year":"2017","unstructured":"Wang J, Feng JQ. Signaling pathways critical for tooth root formation. J Dent Res. 2017;96(11):1221\u20138. https:\/\/doi.org\/10.1177\/0022034517717478.","journal-title":"J Dent Res"},{"issue":"7","key":"327_CR205","doi-asserted-by":"publisher","DOI":"10.1002\/adbi.202400564","volume":"9","author":"C Yin","year":"2025","unstructured":"Yin C, Miao Y, Lu W, Liu Z. IER3 facilitates tumor progression and aberrant glycolysis via activating wnt\/\u03b2-catenin pathway in oral squamous cell carcinoma. Adv Biol (Weinh). 2025;9(7):e2400564. https:\/\/doi.org\/10.1002\/adbi.202400564.","journal-title":"Adv Biol (Weinh)"},{"issue":"20","key":"327_CR206","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1038\/s41388-025-03317-z","volume":"44","author":"X Li","year":"2025","unstructured":"Li X, Zhao H, Jiang E, Liu P, Chen Y, Wang Y, et al. ITGB1\/FERMT1 mechanoactivation enhances CD44 characteristic stemness in oral squamous cell carcinoma via ubiquitin-dependent CK1\u03b1 degradation. Oncogene. 2025;44(20):1530\u201344. https:\/\/doi.org\/10.1038\/s41388-025-03317-z.","journal-title":"Oncogene"},{"issue":"3","key":"327_CR207","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70261","volume":"15","author":"Y Liu","year":"2025","unstructured":"Liu Y, Yang Z, Pu JJ, Zhong J, Khoo US, Su YX, et al. Proteogenomic characterisation of primary oral cancer unveils extracellular matrix remodelling and immunosuppressive microenvironment linked to lymph node metastasis. Clin Transl Med. 2025;15(3):e70261. https:\/\/doi.org\/10.1002\/ctm2.70261.","journal-title":"Clin Transl Med"},{"issue":"2","key":"327_CR208","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70342","volume":"29","author":"S Wang","year":"2025","unstructured":"Wang S, Fan H, Bai J. NKD2 as a mediator of IFIX antioncogene-induced Wnt signalling and epithelial-mesenchymal transition in human OSCC. J Cell Mol Med. 2025;29(2):e70342. https:\/\/doi.org\/10.1111\/jcmm.70342.","journal-title":"J Cell Mol Med"},{"issue":"4","key":"327_CR209","doi-asserted-by":"publisher","first-page":"905","DOI":"10.32604\/or.2024.052089","volume":"33","author":"G You","year":"2025","unstructured":"You G, Yang Q, Li X, Chen L. TMEM33, an oncogene regulated by miR-214-3p, promotes the progression of lung adenocarcinoma through the Wnt\/\u03b2-catenin signaling pathway. Oncol Res. 2025;33(4):905\u201317. https:\/\/doi.org\/10.32604\/or.2024.052089.","journal-title":"Oncol Res"},{"issue":"3","key":"327_CR210","doi-asserted-by":"publisher","DOI":"10.31083\/fbl26898","volume":"30","author":"W Tong","year":"2025","unstructured":"Tong W, Sun J, Shen B, Hu Y, Wang C, Rao M, et al. Transcription factor FOSL1 promotes cisplatin resistance in non-small cell lung cancer cells by modulating the Wnt3a\/\u03b2-catenin signaling through upregulation of PLIN3 expression. Front Biosci (Landmark Ed). 2025;30(3):26898. https:\/\/doi.org\/10.31083\/fbl26898.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"327_CR211","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111330","volume":"122","author":"H Zhao","year":"2024","unstructured":"Zhao H, Wu G, Luo Y, Xie Y, Han Y, Zhang D, et al. WNT5B promotes the malignant phenotype of non-small cell lung cancer via the FZD3-DVL3-RAC1-PCP-JNK pathway. Cell Signal. 2024;122:111330. https:\/\/doi.org\/10.1016\/j.cellsig.2024.111330.","journal-title":"Cell Signal"},{"issue":"1","key":"327_CR212","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12931-017-0537-6","volume":"18","author":"M Vesel","year":"2017","unstructured":"Vesel M, Rapp J, Feller D, Kiss E, Jaromi L, Meggyes M, et al. ABCB1 and ABCG2 drug transporters are differentially expressed in non-small cell lung cancers (NSCLC) and expression is modified by cisplatin treatment via altered Wnt signaling. Respir Res. 2017;18(1):52. https:\/\/doi.org\/10.1186\/s12931-017-0537-6.","journal-title":"Respir Res"},{"issue":"1","key":"327_CR213","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1186\/s12885-016-2943-4","volume":"16","author":"J Rapp","year":"2016","unstructured":"Rapp J, Kiss E, Meggyes M, Szabo-Meleg E, Feller D, Smuk G, et al. Increased Wnt5a in squamous cell lung carcinoma inhibits endothelial cell motility. BMC Cancer. 2016;16(1):915. https:\/\/doi.org\/10.1186\/s12885-016-2943-4.","journal-title":"BMC Cancer"},{"issue":"10","key":"327_CR214","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/ncb3613","volume":"19","author":"X Zhuang","year":"2017","unstructured":"Zhuang X, Zhang H, Li X, Li X, Cong M, Peng F, et al. Differential effects on lung and bone metastasis of breast cancer by Wnt signalling inhibitor DKK1. Nat Cell Biol. 2017;19(10):1274\u201385. https:\/\/doi.org\/10.1038\/ncb3613.","journal-title":"Nat Cell Biol"},{"issue":"49","key":"327_CR215","doi-asserted-by":"publisher","first-page":"6641","DOI":"10.1038\/s41388-021-01941-z","volume":"40","author":"J Zhang","year":"2021","unstructured":"Zhang J, Zhai J, Wong CC, Chen H, Wang X, Ji J, et al. A novel amplification gene PCI domain containing 2 (PCID2) promotes colorectal cancer through directly degrading a tumor suppressor promyelocytic leukemia (PML). Oncogene. 2021;40(49):6641\u201352. https:\/\/doi.org\/10.1038\/s41388-021-01941-z.","journal-title":"Oncogene"},{"issue":"50","key":"327_CR216","doi-asserted-by":"publisher","first-page":"20224","DOI":"10.1073\/pnas.1314239110","volume":"110","author":"J Liu","year":"2013","unstructured":"Liu J, Pan S, Hsieh MH, Ng N, Sun F, Wang T, et al. Targeting wnt-driven cancer through the inhibition of Porcupine by LGK974. Proc Natl Acad Sci U S A. 2013;110(50):20224\u20139. https:\/\/doi.org\/10.1073\/pnas.1314239110.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"327_CR217","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/labinvest.2015.150","volume":"96","author":"JD Boone","year":"2016","unstructured":"Boone JD, Arend RC, Johnston BE, Cooper SJ, Gilchrist SA, Oelschlager DK, et al. Targeting the Wnt\/\u03b2-catenin pathway in primary ovarian cancer with the porcupine inhibitor WNT974. Lab Invest. 2016;96(2):249\u201359. https:\/\/doi.org\/10.1038\/labinvest.2015.150.","journal-title":"Lab Invest"},{"issue":"5","key":"327_CR218","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054759","volume":"24","author":"K Chua","year":"2023","unstructured":"Chua K, Sim AYL, Yeo EYM, Bin Masroni MS, Naw WW, Leong SM, et al. ETC-159, an upstream Wnt inhibitor, induces tumour necrosis via modulation of angiogenesis in osteosarcoma. Int J Mol Sci. 2023;24(5):4759. https:\/\/doi.org\/10.3390\/ijms24054759.","journal-title":"Int J Mol Sci"},{"issue":"17","key":"327_CR219","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1038\/onc.2015.280","volume":"35","author":"B Madan","year":"2016","unstructured":"Madan B, Ke Z, Harmston N, Ho SY, Frois AO, Alam J, et al. Wnt addiction of genetically defined cancers reversed by PORCN inhibition. Oncogene. 2016;35(17):2197\u2013207. https:\/\/doi.org\/10.1038\/onc.2015.280.","journal-title":"Oncogene"},{"issue":"40","key":"327_CR220","doi-asserted-by":"publisher","first-page":"6662","DOI":"10.1038\/s41388-019-0908-1","volume":"38","author":"Z Zhong","year":"2019","unstructured":"Zhong Z, Sepramaniam S, Chew XH, Wood K, Lee MA, Madan B, et al. PORCN inhibition synergizes with PI3K\/mTOR inhibition in Wnt-addicted cancers. Oncogene. 2019;38(40):6662\u201377. https:\/\/doi.org\/10.1038\/s41388-019-0908-1.","journal-title":"Oncogene"},{"key":"327_CR221","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12030766","author":"WN Goldsberry","year":"2020","unstructured":"Goldsberry WN, Meza-Perez S, Londo\u00f1o AI, Katre AA, Mott BT, Roane BM, et al. Inhibiting WNT ligand production for improved immune recognition in the ovarian tumor microenvironment. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12030766.","journal-title":"Cancers (Basel)"},{"issue":"9","key":"327_CR222","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.ymthe.2019.06.013","volume":"27","author":"C Li","year":"2019","unstructured":"Li C, Liang Y, Cao J, Zhang N, Wei X, Tu M, et al. The delivery of a Wnt pathway inhibitor toward CSCs requires stable liposome encapsulation and delayed drug release in tumor tissues. Mol Ther. 2019;27(9):1558\u201367. https:\/\/doi.org\/10.1016\/j.ymthe.2019.06.013.","journal-title":"Mol Ther"},{"key":"327_CR223","doi-asserted-by":"publisher","unstructured":"Ma H, Chen Q, Zhu F, Zheng J, Li J, Zhang H, et al.\u00a0Discovery and characterization of a potent Wnt and hedgehog signaling pathways dual inhibitor.\u00a0Eur J Med Chem. 2018;149110\u2013121. https:\/\/doi.org\/10.1016\/j.ejmech.2018.02.034.","DOI":"10.1016\/j.ejmech.2018.02.034"},{"key":"327_CR224","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175628","volume":"945","author":"Q Yang","year":"2023","unstructured":"Yang Q, Qin T, An T, Wu H, Xu G, Xiang J, et al. Novel PORCN inhibitor WHN-88 targets Wnt\/\u03b2-catenin pathway and prevents the growth of Wnt-driven cancers. Eur J Pharmacol. 2023;945:175628. https:\/\/doi.org\/10.1016\/j.ejphar.2023.175628.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"327_CR225","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.70054","volume":"13","author":"MA Paul","year":"2025","unstructured":"Paul MA, Wainwright CL, Hector EE, Ryberg E, Leslie SJ, Walsh SK. Short-term oral administration of the Porcupine inhibitor, Wnt-c59, improves the structural and functional features of experimental HFpEF. Pharmacol Res Perspect. 2025;13(1):e70054. https:\/\/doi.org\/10.1002\/prp2.70054.","journal-title":"Pharmacol Res Perspect"},{"issue":"7","key":"327_CR226","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1021\/acsmedchemlett.6b00038","volume":"7","author":"D Cheng","year":"2016","unstructured":"Cheng D, Liu J, Han D, Zhang G, Gao W, Hsieh MH, et al. Discovery of pyridinyl acetamide derivatives as potent, selective, and orally bioavailable porcupine inhibitors. ACS Med Chem Lett. 2016;7(7):676\u201380. https:\/\/doi.org\/10.1021\/acsmedchemlett.6b00038.","journal-title":"ACS Med Chem Lett"},{"issue":"9","key":"327_CR227","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1158\/2767-9764.Crc-21-0095","volume":"2","author":"C Phillips","year":"2022","unstructured":"Phillips C, Bhamra I, Eagle C, Flanagan E, Armer R, Jones CD, et al. The wnt pathway inhibitor RXC004 blocks tumor growth and reverses immune evasion in wnt ligand-dependent cancer models. Cancer Res Commun. 2022;2(9):914\u201328. https:\/\/doi.org\/10.1158\/2767-9764.Crc-21-0095.","journal-title":"Cancer Res Commun"},{"key":"327_CR228","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2014.08.005","volume":"146","author":"PN Le","year":"2015","unstructured":"Le PN, McDermott JD, Jimeno A. Targeting the Wnt pathway in human cancers: therapeutic targeting with a focus on OMP-54F28. Pharmacol Ther. 2015;146:1\u201311. https:\/\/doi.org\/10.1016\/j.pharmthera.2014.08.005.","journal-title":"Pharmacol Ther."},{"issue":"29","key":"327_CR229","doi-asserted-by":"publisher","first-page":"11717","DOI":"10.1073\/pnas.1120068109","volume":"109","author":"A Gurney","year":"2012","unstructured":"Gurney A, Axelrod F, Bond CJ, Cain J, Chartier C, Donigan L, et al. Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors. Proc Natl Acad Sci U S A. 2012;109(29):11717\u201322. https:\/\/doi.org\/10.1073\/pnas.1120068109.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"53","key":"327_CR230","doi-asserted-by":"publisher","first-page":"91459","DOI":"10.18632\/oncotarget.20665","volume":"8","author":"W Zhang","year":"2017","unstructured":"Zhang W, Lu W, Ananthan S, Suto MJ, Li Y. Discovery of novel frizzled-7 inhibitors by targeting the receptor\u2019s transmembrane domain. Oncotarget. 2017;8(53):91459\u201370. https:\/\/doi.org\/10.18632\/oncotarget.20665.","journal-title":"Oncotarget"},{"issue":"6","key":"327_CR231","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/s41589-018-0035-2","volume":"14","author":"AH Nile","year":"2018","unstructured":"Nile AH, de Sousa EMF, Mukund S, Piskol R, Hansen S, Zhou L, et al. A selective peptide inhibitor of Frizzled 7 receptors disrupts intestinal stem cells. Nat Chem Biol. 2018;14(6):582\u201390. https:\/\/doi.org\/10.1038\/s41589-018-0035-2.","journal-title":"Nat Chem Biol"},{"issue":"17","key":"327_CR232","doi-asserted-by":"publisher","first-page":"7739","DOI":"10.1021\/acs.jmedchem.9b00500","volume":"62","author":"S Hansen","year":"2019","unstructured":"Hansen S, Nile AH, Mehta SC, Fuhrmann J, Hannoush RN. Lead optimization yields high affinity frizzled 7-targeting peptides that modulate Clostridium difficile toxin B pathogenicity in epithelial cells. J Med Chem. 2019;62(17):7739\u201350. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b00500.","journal-title":"J Med Chem"},{"issue":"7","key":"327_CR233","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1089\/cmb.2019.0311","volume":"27","author":"I Alves Pinto","year":"2020","unstructured":"Alves Pinto I, Freitas Da Silveira NJ. In silico identification of potential inhibitors of the Wnt signaling pathway in human breast cancer. J Comput Biol. 2020;27(7):999\u20131010. https:\/\/doi.org\/10.1089\/cmb.2019.0311.","journal-title":"J Comput Biol"},{"key":"327_CR234","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.108616","volume":"162","author":"X Sun","year":"2025","unstructured":"Sun X, Jabeen A, Zhang L, Li C, Serfraz S. G-protein-coupled receptor FZD7 as a therapeutic target in glioblastoma: multi-cohort validation and identification of cycloartobiloxanthone as an inhibitor. Bioorg Chem. 2025;162:108616. https:\/\/doi.org\/10.1016\/j.bioorg.2025.108616.","journal-title":"Bioorg Chem"},{"issue":"3","key":"327_CR235","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s10549-017-4641-6","volume":"169","author":"N Zarei","year":"2018","unstructured":"Zarei N, Fazeli M, Mohammadi M, Nejatollahi F. Cell growth inhibition and apoptosis in breast cancer cells induced by anti-FZD7 scFvs: involvement of bioinformatics-based design of novel epitopes. Breast Cancer Res Treat. 2018;169(3):427\u201336. https:\/\/doi.org\/10.1007\/s10549-017-4641-6.","journal-title":"Breast Cancer Res Treat"},{"key":"327_CR236","doi-asserted-by":"publisher","unstructured":"Riley RS, Day ES. Frizzled7 Antibody-Functionalized Nanoshells Enable Multivalent Binding for Wnt Signaling Inhibition in Triple Negative Breast Cancer Cells. Small. 2017;13(26). https:\/\/doi.org\/10.1002\/smll.201700544.","DOI":"10.1002\/smll.201700544"},{"issue":"51","key":"327_CR237","doi-asserted-by":"publisher","first-page":"30596","DOI":"10.1074\/jbc.M115.673202","volume":"290","author":"HJ Lee","year":"2015","unstructured":"Lee HJ, Bao J, Miller A, Zhang C, Wu J, Baday YC, et al. Structure-based discovery of novel small molecule Wnt signaling inhibitors by targeting the cysteine-rich domain of Frizzled. J Biol Chem. 2015;290(51):30596\u2013606. https:\/\/doi.org\/10.1074\/jbc.M115.673202.","journal-title":"J Biol Chem"},{"issue":"1","key":"327_CR238","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4544-x","volume":"18","author":"AL Giraudet","year":"2018","unstructured":"Giraudet AL, Cassier PA, Iwao-Fukukawa C, Garin G, Badel JN, Kryza D, et al. A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients. BMC Cancer. 2018;18(1):646. https:\/\/doi.org\/10.1186\/s12885-018-4544-x.","journal-title":"BMC Cancer"},{"key":"327_CR239","doi-asserted-by":"publisher","unstructured":"Pavlovic Z, Adams JJ, Blazer LL, Gakhal AK, Jarvik N, Steinhart Z, et al. A synthetic anti-Frizzled antibody engineered for broadened specificity exhibits enhanced anti-tumor properties. MAbs. 2018;10(8):1157\u201367. https:\/\/doi.org\/10.1080\/19420862.2018.1515565.","DOI":"10.1080\/19420862.2018.1515565"},{"issue":"5","key":"327_CR240","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.chembiol.2020.02.009","volume":"27","author":"H Chen","year":"2020","unstructured":"Chen H, Lu C, Ouyang B, Zhang H, Huang Z, Bhatia D, et al. Development of Potent, Selective Surrogate WNT Molecules and Their Application in Defining Frizzled Requirements. Cell Chem Biol. 2020;27(5):598-609.e4. https:\/\/doi.org\/10.1016\/j.chembiol.2020.02.009.","journal-title":"Cell Chem Biol"},{"issue":"32","key":"327_CR241","doi-asserted-by":"publisher","first-page":"13253","DOI":"10.1073\/pnas.1110431108","volume":"108","author":"D Lu","year":"2011","unstructured":"Lu D, Choi MY, Yu J, Castro JE, Kipps TJ, Carson DA. Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells. Proc Natl Acad Sci U S A. 2011;108(32):13253\u20137. https:\/\/doi.org\/10.1073\/pnas.1110431108.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"327_CR242","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3892\/or.2013.2524","volume":"30","author":"W Shen","year":"2013","unstructured":"Shen W, Zou X, Chen M, Shen Y, Huang S, Guo H, et al. Effect of pantoprazole on human gastric adenocarcinoma SGC7901 cells through regulation of phospho-LRP6 expression in Wnt\/\u03b2-catenin signaling. Oncol Rep. 2013;30(2):851\u20135. https:\/\/doi.org\/10.3892\/or.2013.2524.","journal-title":"Oncol Rep"},{"issue":"12","key":"327_CR243","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029290","volume":"6","author":"W Lu","year":"2011","unstructured":"Lu W, Lin C, Roberts MJ, Waud WR, Piazza GA, Li Y. Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt\/\u03b2-catenin pathway. PLoS ONE. 2011;6(12):e29290. https:\/\/doi.org\/10.1371\/journal.pone.0029290.","journal-title":"PLoS ONE"},{"issue":"22","key":"327_CR244","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1021\/bi1001486","volume":"49","author":"W Lu","year":"2010","unstructured":"Lu W, Liu CC, Thottassery JV, Bu G, Li Y. Mesd is a universal inhibitor of Wnt coreceptors LRP5 and LRP6 and blocks Wnt\/beta-catenin signaling in cancer cells. Biochemistry. 2010;49(22):4635\u201343. https:\/\/doi.org\/10.1021\/bi1001486.","journal-title":"Biochemistry"},{"issue":"6","key":"327_CR245","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.bmcl.2018.01.050","volume":"28","author":"J Choi","year":"2018","unstructured":"Choi J, Lee K, Kang M, Lim SK, Tai No K. In silico discovery of quinoxaline derivatives as novel LRP5\/6-sclerostin interaction inhibitors. Bioorg Med Chem Lett. 2018;28(6):1116\u201321. https:\/\/doi.org\/10.1016\/j.bmcl.2018.01.050.","journal-title":"Bioorg Med Chem Lett"},{"issue":"11","key":"327_CR246","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1158\/1541-7786.Mcr-15-0204","volume":"13","author":"MD Arensman","year":"2015","unstructured":"Arensman MD, Nguyen P, Kershaw KM, Lay AR, Ostertag-Hill CA, Sherman MH, et al. Calcipotriol targets LRP6 to inhibit Wnt signaling in pancreatic cancer. Mol Cancer Res. 2015;13(11):1509\u201319. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-15-0204.","journal-title":"Mol Cancer Res"},{"key":"327_CR247","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.biopha.2017.10.045","volume":"97","author":"AK Badana","year":"2018","unstructured":"Badana AK, Chintala M, Gavara MM, Naik S, Kumari S, Kappala VR, et al. Lipid rafts disruption induces apoptosis by attenuating expression of LRP6 and survivin in triple negative breast cancer. Biomed Pharmacother. 2018;97:359\u201368. https:\/\/doi.org\/10.1016\/j.biopha.2017.10.045.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"327_CR248","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1158\/0008-5472.Can-06-2726","volume":"67","author":"N Fujii","year":"2007","unstructured":"Fujii N, You L, Xu Z, Uematsu K, Shan J, He B, et al. An antagonist of dishevelled protein-protein interaction suppresses beta-catenin-dependent tumor cell growth. Cancer Res. 2007;67(2):573\u20139. https:\/\/doi.org\/10.1158\/0008-5472.Can-06-2726.","journal-title":"Cancer Res"},{"issue":"24","key":"327_CR249","doi-asserted-by":"publisher","first-page":"16256","DOI":"10.1074\/jbc.M109.009647","volume":"284","author":"D Grandy","year":"2009","unstructured":"Grandy D, Shan J, Zhang X, Rao S, Akunuru S, Li H, et al. Discovery and characterization of a small molecule inhibitor of the PDZ domain of dishevelled. J Biol Chem. 2009;284(24):16256\u201363. https:\/\/doi.org\/10.1074\/jbc.M109.009647.","journal-title":"J Biol Chem"},{"issue":"7","key":"327_CR250","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27032","volume":"65","author":"S Huang","year":"2018","unstructured":"Huang S, Chen J, Tian R, Wang J, Xie C, Gao H, et al. Down-regulation of dishevelled-2 inhibits cell proliferation and invasion in hepatoblastoma. Pediatr Blood Cancer. 2018;65(7):e27032. https:\/\/doi.org\/10.1002\/pbc.27032.","journal-title":"Pediatr Blood Cancer"},{"key":"327_CR251","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2017.11.004","volume":"414","author":"SR Martins-Neves","year":"2018","unstructured":"Martins-Neves SR, Paiva-Oliveira DI, Fontes-Ribeiro C, Bov\u00e9e J, Cleton-Jansen AM, Gomes CMF. Cancer Lett. 2018;414:1\u201315. https:\/\/doi.org\/10.1016\/j.canlet.2017.11.004.","journal-title":"Cancer Lett."},{"issue":"7264","key":"327_CR252","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/nature08356","volume":"461","author":"SM Huang","year":"2009","unstructured":"Huang SM, Mishina YM, Liu S, Cheung A, Stegmeier F, Michaud GA, et al. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature. 2009;461(7264):614\u201320. https:\/\/doi.org\/10.1038\/nature08356.","journal-title":"Nature"},{"key":"327_CR253","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-211","volume":"13","author":"AM Busch","year":"2013","unstructured":"Busch AM, Johnson KC, Stan RV, Sanglikar A, Ahmed Y, Dmitrovsky E, et al. Evidence for tankyrases as antineoplastic targets in lung cancer. BMC Cancer. 2013;13:211. https:\/\/doi.org\/10.1186\/1471-2407-13-211.","journal-title":"BMC Cancer"},{"issue":"1","key":"327_CR254","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-36447-4","volume":"9","author":"M Menon","year":"2019","unstructured":"Menon M, Elliott R, Bowers L, Balan N, Rafiq R, Costa-Cabral S, et al. A novel tankyrase inhibitor, MSC2504877, enhances the effects of clinical CDK4\/6 inhibitors. Sci Rep. 2019;9(1):201. https:\/\/doi.org\/10.1038\/s41598-018-36447-4.","journal-title":"Sci Rep"},{"issue":"1","key":"327_CR255","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/cam4.170","volume":"3","author":"EW Stratford","year":"2014","unstructured":"Stratford EW, Daffinrud J, Munthe E, Castro R, Waaler J, Krauss S, et al. The tankyrase-specific inhibitor JW74 affects cell cycle progression and induces apoptosis and differentiation in osteosarcoma cell lines. Cancer Med. 2014;3(1):36\u201346. https:\/\/doi.org\/10.1002\/cam4.170.","journal-title":"Cancer Med"},{"issue":"12","key":"327_CR256","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1111\/cas.13805","volume":"109","author":"A Mizutani","year":"2018","unstructured":"Mizutani A, Yashiroda Y, Muramatsu Y, Yoshida H, Chikada T, Tsumura T, et al. RK-287107, a potent and specific tankyrase inhibitor, blocks colorectal cancer cell growth in a preclinical model. Cancer Sci. 2018;109(12):4003\u201314. https:\/\/doi.org\/10.1111\/cas.13805.","journal-title":"Cancer Sci"},{"issue":"11","key":"327_CR257","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1158\/0008-5472.Can-11-3336","volume":"72","author":"J Waaler","year":"2012","unstructured":"Waaler J, Machon O, Tumova L, Dinh H, Korinek V, Wilson SR, et al. A novel tankyrase inhibitor decreases canonical Wnt signaling in colon carcinoma cells and reduces tumor growth in conditional APC mutant mice. Cancer Res. 2012;72(11):2822\u201332. https:\/\/doi.org\/10.1158\/0008-5472.Can-11-3336.","journal-title":"Cancer Res"},{"issue":"19","key":"327_CR258","doi-asserted-by":"publisher","first-page":"28273","DOI":"10.18632\/oncotarget.8626","volume":"7","author":"KS Quackenbush","year":"2016","unstructured":"Quackenbush KS, Bagby S, Tai WM, Messersmith WA, Schreiber A, Greene J, et al. The novel tankyrase inhibitor (AZ1366) enhances irinotecan activity in tumors that exhibit elevated tankyrase and irinotecan resistance. Oncotarget. 2016;7(19):28273\u201385. https:\/\/doi.org\/10.18632\/oncotarget.8626.","journal-title":"Oncotarget"},{"issue":"10","key":"327_CR259","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1158\/0008-5472.Can-12-4562","volume":"73","author":"T Lau","year":"2013","unstructured":"Lau T, Chan E, Callow M, Waaler J, Boggs J, Blake RA, et al. A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth. Cancer Res. 2013;73(10):3132\u201344. https:\/\/doi.org\/10.1158\/0008-5472.Can-12-4562.","journal-title":"Cancer Res"},{"key":"327_CR260","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25071680","author":"B Li","year":"2020","unstructured":"Li B, Liang J, Lu F, Zeng G, Zhang J, Ma Y, et al. Discovery of novel inhibitor for WNT\/\u03b2-catenin pathway by tankyrase 1\/2 structure-based virtual screening. Molecules. 2020. https:\/\/doi.org\/10.3390\/molecules25071680.","journal-title":"Molecules"},{"issue":"1","key":"327_CR261","doi-asserted-by":"publisher","first-page":"4184","DOI":"10.1038\/s41467-019-12143-3","volume":"10","author":"L Ji","year":"2019","unstructured":"Ji L, Lu B, Zamponi R, Charlat O, Aversa R, Yang Z, et al. Usp7 inhibits Wnt\/\u03b2-catenin signaling through promoting stabilization of Axin. Nat Commun. 2019;10(1):4184. https:\/\/doi.org\/10.1038\/s41467-019-12143-3.","journal-title":"Nat Commun"},{"key":"327_CR262","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ejca.2022.06.031","volume":"173","author":"DY Kim","year":"2022","unstructured":"Kim DY, Kwon YJ, Seo WY, Kim UI, Ahn S, Choi SM, et al. Tankyrase-selective inhibitor STP1002 shows preclinical antitumour efficacy without on-target toxicity in the gastrointestinal tract. Eur J Cancer. 2022;173:41\u201351. https:\/\/doi.org\/10.1016\/j.ejca.2022.06.031.","journal-title":"Eur J Cancer"},{"issue":"10","key":"327_CR263","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102479","volume":"298","author":"J Fan","year":"2022","unstructured":"Fan J, Reid RR, He TC. Pyrvinium doubles against WNT-driven cancer. J Biol Chem. 2022;298(10):102479. https:\/\/doi.org\/10.1016\/j.jbc.2022.102479.","journal-title":"J Biol Chem"},{"issue":"11","key":"327_CR264","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nchembio.453","volume":"6","author":"CA Thorne","year":"2010","unstructured":"Thorne CA, Hanson AJ, Schneider J, Tahinci E, Orton D, Cselenyi CS, et al. Small-molecule inhibition of Wnt signaling through activation of casein kinase 1\u03b1. Nat Chem Biol. 2010;6(11):829\u201336. https:\/\/doi.org\/10.1038\/nchembio.453.","journal-title":"Nat Chem Biol"},{"key":"327_CR265","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aak9916","author":"B Li","year":"2017","unstructured":"Li B, Orton D, Neitzel LR, Astudillo L, Shen C, Long J, et al. Differential abundance of CK1\u03b1 provides selectivity for pharmacological CK1\u03b1 activators to target WNT-dependent tumors. Sci Signal. 2017. https:\/\/doi.org\/10.1126\/scisignal.aak9916.","journal-title":"Sci Signal"},{"issue":"8","key":"327_CR266","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.chembiol.2017.06.013","volume":"24","author":"L Dietrich","year":"2017","unstructured":"Dietrich L, Rathmer B, Ewan K, Bange T, Heinrichs S, Dale TC, et al. Cell Permeable Stapled Peptide Inhibitor of Wnt Signaling that Targets \u03b2-Catenin Protein-Protein Interactions. Cell Chem Biol. 2017;24(8):958-968.e5. https:\/\/doi.org\/10.1016\/j.chembiol.2017.06.013.","journal-title":"Cell Chem Biol"},{"issue":"5","key":"327_CR267","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110319","volume":"38","author":"R Yan","year":"2022","unstructured":"Yan R, Zhu H, Huang P, Yang M, Shen M, Pan Y, et al. Liquidambaric acid inhibits Wnt\/\u03b2-catenin signaling and colon cancer via targeting TNF receptor-associated factor 2. Cell Rep. 2022;38(5):110319. https:\/\/doi.org\/10.1016\/j.celrep.2022.110319.","journal-title":"Cell Rep"},{"key":"327_CR268","doi-asserted-by":"publisher","DOI":"10.3390\/md20020125","author":"M Sun","year":"2022","unstructured":"Sun M, Zhou D, Wu J, Zhou J, Xu J. Sdy-1 executes antitumor activity in HepG2 and HeLa cancer cells by inhibiting the Wnt\/\u03b2-catenin signaling pathway. Mar Drugs. 2022. https:\/\/doi.org\/10.3390\/md20020125.","journal-title":"Mar Drugs"},{"key":"327_CR269","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cellsig.2019.03.014","volume":"59","author":"G Qin","year":"2019","unstructured":"Qin G, Li Y, Xu X, Wang X, Zhang K, Tang Y, et al. Panobinostat (LBH589) inhibits Wnt\/\u03b2-catenin signaling pathway via upregulating APCL expression in breast cancer. Cell Signal. 2019;59:62\u201375. https:\/\/doi.org\/10.1016\/j.cellsig.2019.03.014.","journal-title":"Cell Signal"},{"key":"327_CR270","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24061146","author":"ZN Ye","year":"2019","unstructured":"Ye ZN, Yuan F, Liu JQ, Peng XR, An T, Li X, et al. Physalis peruviana-derived 4\u03b2-hydroxywithanolide E, a novel antagonist of Wnt signaling, inhibits colorectal cancer in vitro and in vivo. Molecules. 2019. https:\/\/doi.org\/10.3390\/molecules24061146.","journal-title":"Molecules"},{"issue":"1","key":"327_CR271","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-60784-y","volume":"10","author":"A Cheltsov","year":"2020","unstructured":"Cheltsov A, Nomura N, Yenugonda VM, Roper J, Mukthavaram R, Jiang P, et al. Allosteric inhibitor of \u03b2-catenin selectively targets oncogenic Wnt signaling in colon cancer. Sci Rep. 2020;10(1):8096. https:\/\/doi.org\/10.1038\/s41598-020-60784-y.","journal-title":"Sci Rep"},{"issue":"17","key":"327_CR272","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abm3108","volume":"8","author":"H Tanton","year":"2022","unstructured":"Tanton H, Sewastianik T, Seo HS, Remillard D, Pierre RS, Bala P, et al. A novel \u03b2-catenin\/BCL9 complex inhibitor blocks oncogenic Wnt signaling and disrupts cholesterol homeostasis in colorectal cancer. Sci Adv. 2022;8(17):eabm3108. https:\/\/doi.org\/10.1126\/sciadv.abm3108.","journal-title":"Sci Adv"},{"key":"327_CR273","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2021.128161","volume":"45","author":"T Matsumoto","year":"2021","unstructured":"Matsumoto T, Kitagawa T, Imahori D, Matsuzaki A, Saito Y, Ohta T, et al. Linderapyrone: a Wnt signal inhibitor isolated from Lindera umbellata. Bioorg Med Chem Lett. 2021;45:128161. https:\/\/doi.org\/10.1016\/j.bmcl.2021.128161.","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"327_CR274","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/s1535-6108(03)00334-9","volume":"5","author":"M Lepourcelet","year":"2004","unstructured":"Lepourcelet M, Chen YN, France DS, Wang H, Crews P, Petersen F, et al. Small-molecule antagonists of the oncogenic Tcf\/beta-catenin protein complex. Cancer Cell. 2004;5(1):91\u2013102. https:\/\/doi.org\/10.1016\/s1535-6108(03)00334-9.","journal-title":"Cancer Cell"},{"issue":"22","key":"327_CR275","doi-asserted-by":"publisher","first-page":"10831","DOI":"10.1158\/0008-5472.Can-07-0908","volume":"67","author":"T Yamashita","year":"2007","unstructured":"Yamashita T, Budhu A, Forgues M, Wang XW. Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma. Cancer Res. 2007;67(22):10831\u20139. https:\/\/doi.org\/10.1158\/0008-5472.Can-07-0908.","journal-title":"Cancer Res"},{"issue":"4","key":"327_CR276","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1593\/neo.91972","volume":"12","author":"RK Gandhirajan","year":"2010","unstructured":"Gandhirajan RK, Staib PA, Minke K, Gehrke I, Plickert G, Schl\u00f6sser A, et al. Small molecule inhibitors of Wnt\/beta-catenin\/lef-1 signaling induces apoptosis in chronic lymphocytic leukemia cells in vitro and in vivo. Neoplasia. 2010;12(4):326\u201335. https:\/\/doi.org\/10.1593\/neo.91972.","journal-title":"Neoplasia"},{"issue":"11","key":"327_CR277","doi-asserted-by":"publisher","first-page":"4678","DOI":"10.1021\/acs.jmedchem.5b00223","volume":"58","author":"JL Catrow","year":"2015","unstructured":"Catrow JL, Zhang Y, Zhang M, Ji H. Discovery of selective small-molecule inhibitors for the \u03b2-catenin\/T-cell factor protein-protein interaction through the optimization of the acyl hydrazone moiety. J Med Chem. 2015;58(11):4678\u201392. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00223.","journal-title":"J Med Chem"},{"issue":"9","key":"327_CR278","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1111\/cas.12471","volume":"105","author":"HJ Lenz","year":"2014","unstructured":"Lenz HJ, Kahn M. Safely targeting cancer stem cells via selective catenin coactivator antagonism. Cancer Sci. 2014;105(9):1087\u201392. https:\/\/doi.org\/10.1111\/cas.12471.","journal-title":"Cancer Sci"},{"issue":"6","key":"327_CR279","doi-asserted-by":"publisher","first-page":"5413","DOI":"10.1002\/jcp.29429","volume":"235","author":"C Evangelisti","year":"2020","unstructured":"Evangelisti C, Chiarini F, Cappellini A, Paganelli F, Fini M, Santi S, et al. Targeting Wnt\/\u03b2-catenin and PI3K\/Akt\/mTOR pathways in T-cell acute lymphoblastic leukemia. J Cell Physiol. 2020;235(6):5413\u201328. https:\/\/doi.org\/10.1002\/jcp.29429.","journal-title":"J Cell Physiol"},{"issue":"10","key":"327_CR280","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1158\/1535-7163.Mct-13-1005","volume":"13","author":"MD Arensman","year":"2014","unstructured":"Arensman MD, Telesca D, Lay AR, Kershaw KM, Wu N, Donahue TR, et al. The CREB-binding protein inhibitor ICG-001 suppresses pancreatic cancer growth. Mol Cancer Ther. 2014;13(10):2303\u201314. https:\/\/doi.org\/10.1158\/1535-7163.Mct-13-1005.","journal-title":"Mol Cancer Ther"},{"issue":"5","key":"327_CR281","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0155983","volume":"11","author":"HS Won","year":"2016","unstructured":"Won HS, Lee KM, Oh JE, Nam EM, Lee KE. Inhibition of \u03b2-catenin to overcome endocrine resistance in tamoxifen-resistant breast cancer cell line. PLoS ONE. 2016;11(5):e0155983. https:\/\/doi.org\/10.1371\/journal.pone.0155983.","journal-title":"PLoS ONE"},{"issue":"3","key":"327_CR282","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1158\/1078-0432.Ccr-18-2554","volume":"25","author":"G Wu","year":"2019","unstructured":"Wu G, Cao L, Zhu J, Tan Z, Tang M, Li Z, et al. Loss of RBMS3 confers platinum resistance in epithelial ovarian cancer via activation of miR-126-5p\/\u03b2-catenin\/CBP signaling. Clin Cancer Res. 2019;25(3):1022\u201335. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-18-2554.","journal-title":"Clin Cancer Res"},{"key":"327_CR283","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ejmech.2018.01.087","volume":"147","author":"Q Xiang","year":"2018","unstructured":"Xiang Q, Wang C, Zhang Y, Xue X, Song M, Zhang C, et al. Discovery and optimization of 1-(1H-indol-1-yl)ethanone derivatives as CBP\/EP300 bromodomain inhibitors for the treatment of castration-resistant prostate cancer. Eur J Med Chem. 2018;147:238\u201352. https:\/\/doi.org\/10.1016\/j.ejmech.2018.01.087.","journal-title":"Eur J Med Chem"},{"issue":"22","key":"327_CR284","doi-asserted-by":"publisher","first-page":"9162","DOI":"10.1021\/acs.jmedchem.7b00796","volume":"60","author":"FA Romero","year":"2017","unstructured":"Romero FA, Murray J, Lai KW, Tsui V, Albrecht BK, An L, et al. GNE-781, a highly advanced potent and selective bromodomain inhibitor of cyclic adenosine monophosphate response element binding protein, binding protein (CBP). J Med Chem. 2017;60(22):9162\u201383. https:\/\/doi.org\/10.1021\/acs.jmedchem.7b00796.","journal-title":"J Med Chem"},{"issue":"1","key":"327_CR285","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1158\/0008-5472.Can-10-1282","volume":"71","author":"J Waaler","year":"2011","unstructured":"Waaler J, Machon O, von Kries JP, Wilson SR, Lundenes E, Wedlich D, et al. Novel synthetic antagonists of canonical Wnt signaling inhibit colorectal cancer cell growth. Cancer Res. 2011;71(1):197\u2013205. https:\/\/doi.org\/10.1158\/0008-5472.Can-10-1282.","journal-title":"Cancer Res"},{"key":"327_CR286","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.biocel.2018.08.012","volume":"103","author":"Y Luo","year":"2018","unstructured":"Luo Y, Tan W, Jia W, Liu Z, Ye P, Fu Z, et al. The long non-coding RNA LINC01606 contributes to the metastasis and invasion of human gastric cancer and is associated with Wnt\/\u03b2-catenin signaling. Int J Biochem Cell Biol. 2018;103:125\u201334. https:\/\/doi.org\/10.1016\/j.biocel.2018.08.012.","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"327_CR287","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1158\/0008-5472.Can-20-0782","volume":"81","author":"K Yamada","year":"2021","unstructured":"Yamada K, Hori Y, Inoue S, Yamamoto Y, Iso K, Kamiyama H, et al. E7386, a selective inhibitor of the interaction between \u03b2-catenin and CBP, exerts antitumor activity in tumor models with activated canonical Wnt signaling. Cancer Res. 2021;81(4):1052\u201362. https:\/\/doi.org\/10.1158\/0008-5472.Can-20-0782.","journal-title":"Cancer Res"},{"issue":"11","key":"327_CR288","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1016\/j.ymthe.2018.09.005","volume":"26","author":"S Ganesh","year":"2018","unstructured":"Ganesh S, Shui X, Craig KP, Park J, Wang W, Brown BD, et al. RNAi-mediated \u03b2-catenin inhibition promotes T cell infiltration and antitumor activity in combination with immune checkpoint blockade. Mol Ther. 2018;26(11):2567\u201379. https:\/\/doi.org\/10.1016\/j.ymthe.2018.09.005.","journal-title":"Mol Ther"},{"issue":"11","key":"327_CR289","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1158\/1535-7163.Mct-21-0273","volume":"20","author":"SJ Klempner","year":"2021","unstructured":"Klempner SJ, Bendell JC, Villaflor VM, Tenner LL, Stein SM, Rottman JB, et al. Safety, efficacy, and biomarker results from a phase Ib study of the anti-DKK1 antibody DKN-01 in combination with pembrolizumab in advanced esophagogastric cancers. Mol Cancer Ther. 2021;20(11):2240\u20139. https:\/\/doi.org\/10.1158\/1535-7163.Mct-21-0273.","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"327_CR290","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1158\/1541-7786.Mcr-20-0799","volume":"19","author":"MS Haas","year":"2021","unstructured":"Haas MS, Kagey MH, Heath H, Schuerpf F, Rottman JB, Newman W. MDKN-01, a novel anti-DKK1 mAb, enhances innate immune responses in the tumor microenvironment. Mol Cancer Res. 2021;19(4):717\u201325. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-20-0799.","journal-title":"Mol Cancer Res"},{"key":"327_CR291","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124211","volume":"659","author":"S Parit","year":"2024","unstructured":"Parit S, Manchare A, Gholap AD, Mundhe P, Hatvate N, Rojekar S, et al. Antibody-drug conjugates: a promising breakthrough in cancer therapy. Int J Pharm. 2024;659:124211. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124211.","journal-title":"Int J Pharm"},{"key":"327_CR292","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1274088","volume":"14","author":"F Riccardi","year":"2023","unstructured":"Riccardi F, Dal Bo M, Macor P, Toffoli G. A comprehensive overview on antibody-drug conjugates: from the conceptualization to cancer therapy. Front Pharmacol. 2023;14:1274088. https:\/\/doi.org\/10.3389\/fphar.2023.1274088.","journal-title":"Front Pharmacol"},{"issue":"314","key":"327_CR293","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aac7433","volume":"7","author":"MR Junttila","year":"2015","unstructured":"Junttila MR, Mao W, Wang X, Wang BE, Pham T, Flygare J, et al. Targeting LGR5+ cells with an antibody-drug conjugate for the treatment of colon cancer. Sci Transl Med. 2015;7(314):314ra186. https:\/\/doi.org\/10.1126\/scitranslmed.aac7433.","journal-title":"Sci Transl Med"},{"issue":"24","key":"327_CR294","doi-asserted-by":"publisher","first-page":"508","DOI":"10.21037\/atm.2016.11.78","volume":"4","author":"D Hirsch","year":"2016","unstructured":"Hirsch D, Ried T. Targeting colorectal cancer (stem-like) cells using LGR5 directed antibody drug conjugates. Ann Transl Med. 2016;4(24):508. https:\/\/doi.org\/10.21037\/atm.2016.11.78.","journal-title":"Ann Transl Med"},{"issue":"43","key":"327_CR295","doi-asserted-by":"publisher","first-page":"6598","DOI":"10.1038\/sj.onc.1205920","volume":"21","author":"CS Rhee","year":"2002","unstructured":"Rhee CS, Sen M, Lu D, Wu C, Leoni L, Rubin J, et al. Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas. Oncogene. 2002;21(43):6598\u2013605. https:\/\/doi.org\/10.1038\/sj.onc.1205920.","journal-title":"Oncogene"},{"issue":"6","key":"327_CR296","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/s41418-018-0187-3","volume":"26","author":"HH Seo","year":"2019","unstructured":"Seo HH, Lee S, Lee CY, Lee J, Shin S, Song BW, et al. Multipoint targeting of TGF-\u03b2\/Wnt transactivation circuit with microRNA 384\u20135p for cardiac fibrosis. Cell Death Differ. 2019;26(6):1107\u201323. https:\/\/doi.org\/10.1038\/s41418-018-0187-3.","journal-title":"Cell Death Differ"},{"issue":"10","key":"327_CR297","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1158\/1535-7163.Mct-22-0216","volume":"21","author":"S Ning","year":"2022","unstructured":"Ning S, Liu C, Lou W, Yang JC, Lombard AP, D\u2019Abronzo LS, et al. Bioengineered BERA-Wnt5a siRNA targeting Wnt5a\/FZD2 signaling suppresses advanced prostate cancer tumor growth and enhances enzalutamide treatment. Mol Cancer Ther. 2022;21(10):1594\u2013607. https:\/\/doi.org\/10.1158\/1535-7163.Mct-22-0216.","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"327_CR298","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41573-021-00162-z","volume":"20","author":"ST Crooke","year":"2021","unstructured":"Crooke ST, Baker BF, Crooke RM, Liang XH. Antisense technology: an overview and prospectus. Nat Rev Drug Discov. 2021;20(6):427\u201353. https:\/\/doi.org\/10.1038\/s41573-021-00162-z.","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"327_CR299","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-02820-3","volume":"11","author":"M Li","year":"2020","unstructured":"Li M, Ding X, Zhang Y, Li X, Zhou H, Yang L, et al. Antisense oligonucleotides targeting lncRNA AC104041.1 induces antitumor activity through Wnt2B\/\u03b2-catenin pathway in head and neck squamous cell carcinomas. Cell Death Dis. 2020;11(8):672. https:\/\/doi.org\/10.1038\/s41419-020-02820-3.","journal-title":"Cell Death Dis"},{"issue":"3","key":"327_CR300","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1096\/fj.15-271999","volume":"30","author":"VB Popov","year":"2016","unstructured":"Popov VB, Jornayvaz FR, Akgul EO, Kanda S, Jurczak MJ, Zhang D, et al. Second-generation antisense oligonucleotides against \u03b2-catenin protect mice against diet-induced hepatic steatosis and hepatic and peripheral insulin resistance. FASEB J. 2016;30(3):1207\u201317. https:\/\/doi.org\/10.1096\/fj.15-271999.","journal-title":"FASEB J"},{"issue":"8","key":"327_CR301","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.chembiol.2020.07.020","volume":"27","author":"DA Nalawansha","year":"2020","unstructured":"Nalawansha DA, Crews CM. PROTACs: an emerging therapeutic modality in precision medicine. Cell Chem Biol. 2020;27(8):998\u20131014. https:\/\/doi.org\/10.1016\/j.chembiol.2020.07.020.","journal-title":"Cell Chem Biol"},{"key":"327_CR302","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-020-0171-1","volume":"6","author":"H Liao","year":"2020","unstructured":"Liao H, Li X, Zhao L, Wang Y, Wang X, Wu Y, et al. A PROTAC peptide induces durable \u03b2-catenin degradation and suppresses Wnt-dependent intestinal cancer. Cell Discov. 2020;6:35. https:\/\/doi.org\/10.1038\/s41421-020-0171-1.","journal-title":"Cell Discov"},{"issue":"6","key":"327_CR303","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2024.189195","volume":"1879","author":"A Goyal","year":"2024","unstructured":"Goyal A, Murkute SL, Bhowmik S, Prasad CP, Mohapatra P. Belling the \u201ccat\u201d: Wnt\/\u03b2-catenin signaling and its significance in future cancer therapies. Biochim Biophys Acta Rev Cancer. 2024;1879(6):189195. https:\/\/doi.org\/10.1016\/j.bbcan.2024.189195.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"15","key":"327_CR304","doi-asserted-by":"publisher","first-page":"10606","DOI":"10.1021\/acs.jmedchem.1c00895","volume":"64","author":"G Dong","year":"2021","unstructured":"Dong G, Ding Y, He S, Sheng C. Molecular glues for targeted protein degradation: from serendipity to rational discovery. J Med Chem. 2021;64(15):10606\u201320. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c00895.","journal-title":"J Med Chem"},{"issue":"3","key":"327_CR305","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1021\/acs.biochem.2c00245","volume":"62","author":"JM Sasso","year":"2023","unstructured":"Sasso JM, Tenchov R, Wang D, Johnson LS, Wang X, Zhou QA. Molecular glues: the adhesive connecting targeted protein degradation to the clinic. Biochemistry. 2023;62(3):601\u201323. https:\/\/doi.org\/10.1021\/acs.biochem.2c00245.","journal-title":"Biochemistry"},{"issue":"1","key":"327_CR306","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09358-9","volume":"10","author":"KR Simonetta","year":"2019","unstructured":"Simonetta KR, Taygerly J, Boyle K, Basham SE, Padovani C, Lou Y, et al. Prospective discovery of small molecule enhancers of an E3 ligase-substrate interaction. Nat Commun. 2019;10(1):1402. https:\/\/doi.org\/10.1038\/s41467-019-09358-9.","journal-title":"Nat Commun"},{"key":"327_CR307","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ctrv.2017.11.002","volume":"62","author":"N Krishnamurthy","year":"2018","unstructured":"Krishnamurthy N, Kurzrock R. Targeting the Wnt\/beta-catenin pathway in cancer: update on effectors and inhibitors. Cancer Treat Rev. 2018;62:50\u201360. https:\/\/doi.org\/10.1016\/j.ctrv.2017.11.002.","journal-title":"Cancer Treat Rev"},{"key":"327_CR308","doi-asserted-by":"publisher","DOI":"10.1038\/s41413-018-0017-8","volume":"6","author":"B Madan","year":"2018","unstructured":"Madan B, McDonald MJ, Foxa GE, Diegel CR, Williams BO, Virshup DM. Bone loss from Wnt inhibition mitigated by concurrent alendronate therapy. Bone Res. 2018;6:17. https:\/\/doi.org\/10.1038\/s41413-018-0017-8.","journal-title":"Bone Res"},{"issue":"6","key":"327_CR309","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1021\/acsmedchemlett.1c00160","volume":"12","author":"D Qin","year":"2021","unstructured":"Qin D, Lin X, Liu Z, Chen Y, Zhang Z, Wu C, et al. Discovery of orally bioavailable ligand efficient quinazolindiones as potent and selective tankyrases inhibitors. ACS Med Chem Lett. 2021;12(6):1005\u201310. https:\/\/doi.org\/10.1021\/acsmedchemlett.1c00160.","journal-title":"ACS Med Chem Lett"},{"issue":"3","key":"327_CR310","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.drudis.2021.12.008","volume":"27","author":"Y Larasati","year":"2022","unstructured":"Larasati Y, Boudou C, Koval A, Katanaev VL. Unlocking the Wnt pathway: therapeutic potential of selective targeting FZD(7) in cancer. Drug Discov Today. 2022;27(3):777\u201392. https:\/\/doi.org\/10.1016\/j.drudis.2021.12.008.","journal-title":"Drug Discov Today"},{"issue":"5","key":"327_CR311","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.3892\/ijo.2017.4129","volume":"51","author":"M Katoh","year":"2017","unstructured":"Katoh M. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (review). Int J Oncol. 2017;51(5):1357\u201369. https:\/\/doi.org\/10.3892\/ijo.2017.4129.","journal-title":"Int J Oncol"},{"issue":"1","key":"327_CR312","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01803-6","volume":"9","author":"M Zhang","year":"2024","unstructured":"Zhang M, Chen T, Lu X, Lan X, Chen Z, Lu S. G protein-coupled receptors (GPCRs): advances in structures, mechanisms, and drug discovery. Signal Transduct Target Ther. 2024;9(1):88. https:\/\/doi.org\/10.1038\/s41392-024-01803-6.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"327_CR313","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1038\/s41591-024-03010-w","volume":"30","author":"V Nauffal","year":"2024","unstructured":"Nauffal V, Klarqvist MDR, Hill MC, Pace DF, Di Achille P, Choi SH, et al. Noninvasive assessment of organ-specific and shared pathways in multi-organ fibrosis using T1 mapping. Nat Med. 2024;30(6):1749\u201360. https:\/\/doi.org\/10.1038\/s41591-024-03010-w.","journal-title":"Nat Med"},{"issue":"3","key":"327_CR314","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.hbpd.2018.03.005","volume":"17","author":"L Wang","year":"2018","unstructured":"Wang L, Yao M, Fang M, Zheng WJ, Dong ZZ, Pan LH, et al. Expression of hepatic Wnt5a and its clinicopathological features in patients with hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2018;17(3):227\u201332. https:\/\/doi.org\/10.1016\/j.hbpd.2018.03.005.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"1","key":"327_CR315","doi-asserted-by":"publisher","DOI":"10.1186\/1756-9966-31-68","volume":"31","author":"A Van den Broeck","year":"2012","unstructured":"Van den Broeck A, Vankelecom H, Van Eijsden R, Govaere O, Topal B. Molecular markers associated with outcome and metastasis in human pancreatic cancer. J Exp Clin Cancer Res. 2012;31(1):68. https:\/\/doi.org\/10.1186\/1756-9966-31-68.","journal-title":"J Exp Clin Cancer Res"},{"key":"327_CR316","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111155","volume":"119","author":"Y Cai","year":"2024","unstructured":"Cai Y, Xia L, Zhu H, Cheng H, Tian Y, Sun L, et al. Mir-3682-3p promotes esophageal cancer progression by targeting FHL1 and activating the Wnt\/\u03b2-catenin signaling pathway. Cell Signal. 2024;119:111155. https:\/\/doi.org\/10.1016\/j.cellsig.2024.111155.","journal-title":"Cell Signal"},{"issue":"2","key":"327_CR317","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/cas.14738","volume":"112","author":"Y Liu","year":"2021","unstructured":"Liu Y, Wu D, Cheng H, Chen L, Zhang W, Zou L, et al. Wnt8B, transcriptionally regulated by ZNF191, promotes cell proliferation of hepatocellular carcinoma via Wnt signaling. Cancer Sci. 2021;112(2):629\u201340. https:\/\/doi.org\/10.1111\/cas.14738.","journal-title":"Cancer Sci"},{"key":"327_CR318","doi-asserted-by":"publisher","unstructured":"Liu Y, Patel L, Mills GB, Lu KH, Sood AK, Ding L, et al. Clinical significance of CTNNB1 mutation and Wnt pathway activation in endometrioid endometrial carcinoma. J Natl Cancer Inst. 2014;106(9). https:\/\/doi.org\/10.1093\/jnci\/dju245.","DOI":"10.1093\/jnci\/dju245"},{"key":"327_CR319","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.12659\/msm.913913","volume":"25","author":"X Xu","year":"2019","unstructured":"Xu X, Liu Z, Tian F, Xu J, Chen Y. Clinical significance of transcription factor 7 (TCF7) as a prognostic factor in gastric cancer. Med Sci Monit. 2019;25:3957\u201363. https:\/\/doi.org\/10.12659\/msm.913913.","journal-title":"Med Sci Monit"},{"issue":"8","key":"327_CR320","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181034","volume":"12","author":"TC Huang","year":"2017","unstructured":"Huang TC, Lee PT, Wu MH, Huang CC, Ko CY, Lee YC, et al. Distinct roles and differential expression levels of Wnt5a mRNA isoforms in colorectal cancer cells. PLoS ONE. 2017;12(8):e0181034. https:\/\/doi.org\/10.1371\/journal.pone.0181034.","journal-title":"PLoS ONE"},{"issue":"2","key":"327_CR321","doi-asserted-by":"publisher","first-page":"537","DOI":"10.7150\/thno.37423","volume":"10","author":"A Kotrbov\u00e1","year":"2020","unstructured":"Kotrbov\u00e1 A, Ovesn\u00e1 P, Gybel T, Radaszkiewicz T, Bedna\u0159\u00edkov\u00e1 M, Hausnerov\u00e1 J, et al. WNT signaling inducing activity in ascites predicts poor outcome in ovarian cancer. Theranostics. 2020;10(2):537\u201352. https:\/\/doi.org\/10.7150\/thno.37423.","journal-title":"Theranostics"},{"issue":"2","key":"327_CR322","doi-asserted-by":"publisher","DOI":"10.1002\/bies.202400110","volume":"47","author":"H Hartmann","year":"2025","unstructured":"Hartmann H, Siddiqui GS, Bryant J, Robbins DJ, Weiss VL, Ahmed Y, et al. Wnt signalosomes: What we know that we do not know. BioEssays. 2025;47(2):e2400110. https:\/\/doi.org\/10.1002\/bies.202400110.","journal-title":"BioEssays"},{"issue":"10","key":"327_CR323","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1002\/jcb.25992","volume":"118","author":"A Bahrami","year":"2017","unstructured":"Bahrami A, Hasanzadeh M, ShahidSales S, Yousefi Z, Kadkhodayan S, Farazestanian M, et al. Clinical significance and prognosis value of Wnt signaling pathway in cervical cancer. J Cell Biochem. 2017;118(10):3028\u201333. https:\/\/doi.org\/10.1002\/jcb.25992.","journal-title":"J Cell Biochem"},{"issue":"11","key":"327_CR324","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1038\/s41374-019-0277-y","volume":"99","author":"Y Tenjin","year":"2019","unstructured":"Tenjin Y, Kudoh S, Kubota S, Yamada T, Matsuo A, Sato Y, et al. Ascl1-induced Wnt11 regulates neuroendocrine differentiation, cell proliferation, and E-cadherin expression in small-cell lung cancer and Wnt11 regulates small-cell lung cancer biology. Lab Invest. 2019;99(11):1622\u201335. https:\/\/doi.org\/10.1038\/s41374-019-0277-y.","journal-title":"Lab Invest"},{"issue":"3","key":"327_CR325","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.hbpd.2022.11.004","volume":"22","author":"M Yao","year":"2023","unstructured":"Yao M, Wang JJ, Chen XY, Sai WL, Yang J, Wang DF, et al. Oncogenic Wnt3a is a promising sensitive biomarker for monitoring hepatocarcinogenesis. Hepatobiliary Pancreat Dis Int. 2023;22(3):263\u20139. https:\/\/doi.org\/10.1016\/j.hbpd.2022.11.004.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"1","key":"327_CR326","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4929-x","volume":"18","author":"M Chovanec","year":"2018","unstructured":"Chovanec M, Cierna Z, Miskovska V, Machalekova K, Kalavska K, Rejlekova K, et al. \u03b2catenin is a marker of poor clinical characteristics and suppressed immune infiltration in testicular germ cell tumors. BMC Cancer. 2018;18(1):1062. https:\/\/doi.org\/10.1186\/s12885-018-4929-x.","journal-title":"BMC Cancer"},{"issue":"5","key":"327_CR327","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41580-024-00823-y","volume":"26","author":"MM Maurice","year":"2025","unstructured":"Maurice MM, Angers S. Mechanistic insights into Wnt-\u03b2-catenin pathway activation and signal transduction. Nat Rev Mol Cell Biol. 2025;26(5):371\u201388. https:\/\/doi.org\/10.1038\/s41580-024-00823-y.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"327_CR328","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00428-018-2370-9","volume":"473","author":"Y Suzuki","year":"2018","unstructured":"Suzuki Y, Ichihara S, Kawasaki T, Yanai H, Kitagawa S, Shimoyama Y, et al. \u03b2-catenin (CTNNB1) mutation and LEF1 expression in sinonasal glomangiopericytoma (sinonasal-type hemangiopericytoma). Virchows Arch. 2018;473(2):235\u20139. https:\/\/doi.org\/10.1007\/s00428-018-2370-9.","journal-title":"Virchows Arch"},{"key":"327_CR329","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12030555","author":"Y Bai","year":"2020","unstructured":"Bai Y, Sha J, Kanno T. The role of carcinogenesis-related biomarkers in the Wnt pathway and their effects on epithelial-mesenchymal transition (EMT) in oral squamous cell carcinoma. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12030555.","journal-title":"Cancers (Basel)"},{"issue":"46","key":"327_CR330","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000013011","volume":"97","author":"K Jiang","year":"2018","unstructured":"Jiang K, Li S, Li L, Wang X, Gu Y, Jin Z. WNT6 is an effective marker for osteosarcoma diagnosis and prognosis. Medicine (Baltimore). 2018;97(46):e13011. https:\/\/doi.org\/10.1097\/md.0000000000013011.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"327_CR331","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3892\/ijmm.2018.3689","volume":"42","author":"M Katoh","year":"2018","unstructured":"Katoh M. Multi-layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT\/\u03b2-catenin signaling activation (Review). Int J Mol Med. 2018;42(2):713\u201325. https:\/\/doi.org\/10.3892\/ijmm.2018.3689.","journal-title":"Int J Mol Med"},{"issue":"2","key":"327_CR332","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1080\/14737159.2020.1702522","volume":"20","author":"RR Fisher","year":"2020","unstructured":"Fisher RR, Pleskow HM, Bedingfield K, Miyamoto DT. Noncanonical Wnt as a prognostic marker in prostate cancer: \u201cyou can\u2019t always get what you Wnt.\u201d Expert Rev Mol Diagn. 2020;20(2):245\u201354. https:\/\/doi.org\/10.1080\/14737159.2020.1702522.","journal-title":"Expert Rev Mol Diagn"},{"issue":"1","key":"327_CR333","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12935-021-01866-3","volume":"21","author":"D Tuluhong","year":"2021","unstructured":"Tuluhong D, Chen T, Wang J, Zeng H, Li H, Dunzhu W, et al. FZD2 promotes TGF-\u03b2-induced epithelial-to-mesenchymal transition in breast cancer via activating notch signaling pathway. Cancer Cell Int. 2021;21(1):199. https:\/\/doi.org\/10.1186\/s12935-021-01866-3.","journal-title":"Cancer Cell Int"},{"key":"327_CR334","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01168","volume":"10","author":"Y Fu","year":"2020","unstructured":"Fu Y, Zheng Q, Mao Y, Jiang X, Chen X, Liu P, et al. WNT2-mediated FZD2 stabilization regulates esophageal cancer metastasis via STAT3 signaling. Front Oncol. 2020;10:1168. https:\/\/doi.org\/10.3389\/fonc.2020.01168.","journal-title":"Front Oncol"},{"issue":"4","key":"327_CR335","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1111\/cas.13949","volume":"110","author":"H Ou","year":"2019","unstructured":"Ou H, Chen Z, Xiang L, Fang Y, Xu Y, Liu Q, et al. Frizzled 2-induced epithelial-mesenchymal transition correlates with vasculogenic mimicry, stemness, and Hippo signaling in hepatocellular carcinoma. Cancer Sci. 2019;110(4):1169\u201382. https:\/\/doi.org\/10.1111\/cas.13949.","journal-title":"Cancer Sci"},{"issue":"2","key":"327_CR336","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.bbrc.2019.04.016","volume":"513","author":"M Luo","year":"2019","unstructured":"Luo M, Zhou L, Zhan SJ, Cheng LJ, Li RN, Wang H, et al. ALPL regulates the aggressive potential of high grade serous ovarian cancer cells via a non-canonical WNT pathway. Biochem Biophys Res Commun. 2019;513(2):528\u201333. https:\/\/doi.org\/10.1016\/j.bbrc.2019.04.016.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"327_CR337","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1177\/0022034520986551","volume":"100","author":"S Sun","year":"2021","unstructured":"Sun S, Wang J, Liu J, Yin F, Xin C, Zeng X, et al. MiR-302b suppresses tumor metastasis by targeting Frizzled 6 in OSCC. J Dent Res. 2021;100(7):739\u201345. https:\/\/doi.org\/10.1177\/0022034520986551.","journal-title":"J Dent Res"},{"issue":"1","key":"327_CR338","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01892-4","volume":"22","author":"JM Ferreira","year":"2024","unstructured":"Ferreira JM, Gon\u00e7alves CS, Costa BM. Emerging roles and biomarker potential of WNT6 in human cancers. Cell Commun Signal. 2024;22(1):538. https:\/\/doi.org\/10.1186\/s12964-024-01892-4.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"327_CR339","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10555-017-9725-6","volume":"37","author":"W Hankey","year":"2018","unstructured":"Hankey W, Frankel WL, Groden J. Functions of the APC tumor suppressor protein dependent and independent of canonical WNT signaling: implications for therapeutic targeting. Cancer Metastasis Rev. 2018;37(1):159\u201372. https:\/\/doi.org\/10.1007\/s10555-017-9725-6.","journal-title":"Cancer Metastasis Rev"},{"key":"327_CR340","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.phrs.2019.02.027","volume":"142","author":"S Chatterjee","year":"2019","unstructured":"Chatterjee S, Sil PC. Targeting the crosstalks of Wnt pathway with Hedgehog and Notch for cancer therapy. Pharmacol Res. 2019;142:251\u201361. https:\/\/doi.org\/10.1016\/j.phrs.2019.02.027.","journal-title":"Pharmacol Res"},{"key":"327_CR341","doi-asserted-by":"publisher","first-page":"110350","DOI":"10.1016\/j.cellsig.2022.110350","volume":"95","author":"S Daisy Precilla","year":"2022","unstructured":"Daisy Precilla S, Biswas I, Kuduvalli SS, Anitha TS. Crosstalk between PI3K\/AKT\/mTOR and WNT\/\u03b2-Catenin signaling in GBM - Could combination therapy checkmate the collusion? Cell Signal. 2022;95:110350. https:\/\/doi.org\/10.1016\/j.cellsig.2022.110350.","journal-title":"Cell Signal."},{"issue":"1","key":"327_CR342","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-018-0581-9","volume":"11","author":"J Zhou","year":"2018","unstructured":"Zhou J, Toh SH, Chan ZL, Quah JY, Chooi JY, Tan TZ, et al. A loss-of-function genetic screening reveals synergistic targeting of AKT\/mTOR and WTN\/\u03b2-catenin pathways for treatment of AML with high PRL-3 phosphatase. J Hematol Oncol. 2018;11(1):36. https:\/\/doi.org\/10.1186\/s13045-018-0581-9.","journal-title":"J Hematol Oncol"},{"issue":"12","key":"327_CR343","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051449","volume":"7","author":"L Mologni","year":"2012","unstructured":"Mologni L, Brussolo S, Ceccon M, Gambacorti-Passerini C. Synergistic effects of combined Wnt\/KRAS inhibition in colorectal cancer cells. PLoS ONE. 2012;7(12):e51449. https:\/\/doi.org\/10.1371\/journal.pone.0051449.","journal-title":"PLoS ONE"},{"key":"327_CR344","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2022.101852","volume":"77","author":"Y Zeng","year":"2022","unstructured":"Zeng Y, Wang T, Liu Y, Luo T, Li Q, He Y, et al. Wnt and Smad signaling pathways synergistically regulated the osteogenic differentiation of fibroblasts in ankylosing spondylitis. Tissue Cell. 2022;77:101852. https:\/\/doi.org\/10.1016\/j.tice.2022.101852.","journal-title":"Tissue Cell"},{"key":"327_CR345","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25115746","author":"MY Jo","year":"2024","unstructured":"Jo MY, Jeong YJ, Song KH, Choi YH, Kwon TK, Chang YC. 4-O-methylascochlorin synergistically enhances 5-fluorouracil-induced apoptosis by inhibiting the Wnt\/\u03b2-catenin signaling pathway in colorectal cancer cells. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25115746.","journal-title":"Int J Mol Sci"},{"key":"327_CR346","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.2147\/ijn.S503540","volume":"20","author":"Z Yang","year":"2025","unstructured":"Yang Z, Zhou M, Yin T, Wang CY, Zhu GY, Bai LP, et al. Functionalized Carbon Dots With Intrinsic Wnt\/\u03b2-Catenin Inhibition to Synergistically Promote 5-Fluorouracil Chemotherapy. Int J Nanomedicine. 2025;20:1951\u201364. https:\/\/doi.org\/10.2147\/ijn.S503540.","journal-title":"Int J Nanomedicine."},{"issue":"1","key":"327_CR347","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2023.2272334","volume":"24","author":"HW Kang","year":"2023","unstructured":"Kang HW, Kim JH, Lee DE, Lee YS, Kim MJ, Kim HS, et al. Combination therapy of niclosamide with gemcitabine inhibited cell proliferation and apoptosis via Wnt\/\u03b2-catenin\/c-Myc signaling pathway by inducing \u03b2-catenin ubiquitination in pancreatic cancer. Cancer Biol Ther. 2023;24(1):2272334. https:\/\/doi.org\/10.1080\/15384047.2023.2272334.","journal-title":"Cancer Biol Ther"},{"key":"327_CR348","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.radonc.2021.06.034","volume":"162","author":"Y Huang","year":"2021","unstructured":"Huang Y, Sheng H, Xiao Y, Hu W, Zhang Z, Chen Y, et al. Wnt\/\u03b2-catenin inhibitor ICG-001 enhances the antitumor efficacy of radiotherapy by increasing radiation-induced DNA damage and improving tumor immune microenvironment in hepatocellular carcinoma. Radiother Oncol. 2021;162:34\u201344. https:\/\/doi.org\/10.1016\/j.radonc.2021.06.034.","journal-title":"Radiother Oncol"},{"issue":"4","key":"327_CR349","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00262-025-03994-5","volume":"74","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Song Y, Li W, Wu J, Zhao Z, Qu T, et al. Clofazimine enhances anti-PD-1 immunotherapy in glioblastoma by inhibiting Wnt6 signaling and modulating the tumor immune microenvironment. Cancer Immunol Immunother. 2025;74(4):137. https:\/\/doi.org\/10.1007\/s00262-025-03994-5.","journal-title":"Cancer Immunol Immunother"},{"issue":"5","key":"327_CR350","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.3892\/or.2017.5945","volume":"38","author":"XY Li","year":"2017","unstructured":"Li XY, Li Y, Zhang L, Liu X, Feng L, Wang X. The antitumor effects of arsenic trioxide in mantle cell lymphoma via targeting Wnt\/\u03b2-catenin pathway and DNA methyltransferase-1. Oncol Rep. 2017;38(5):3114\u201320. https:\/\/doi.org\/10.3892\/or.2017.5945.","journal-title":"Oncol Rep"},{"issue":"16","key":"327_CR351","doi-asserted-by":"publisher","first-page":"13778","DOI":"10.1021\/acs.jmedchem.4c00583","volume":"67","author":"FY Wang","year":"2024","unstructured":"Wang FY, Yang LM, Xiong XL, Yang J, Yang Y, Tang JQ, et al. Rhodium(III) complex noncanonically potentiates antitumor immune responses by inhibiting Wnt\/\u03b2-catenin signaling. J Med Chem. 2024;67(16):13778\u201387. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c00583.","journal-title":"J Med Chem"},{"issue":"6","key":"327_CR352","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.dld.2017.01.146","volume":"49","author":"L Turcios","year":"2017","unstructured":"Turcios L, Vilchez V, Acosta LF, Poyil P, Butterfield DA, Mitov M, et al. Sorafenib and FH535 in combination act synergistically on hepatocellular carcinoma by targeting cell bioenergetics and mitochondrial function. Dig Liver Dis. 2017;49(6):697\u2013704. https:\/\/doi.org\/10.1016\/j.dld.2017.01.146.","journal-title":"Dig Liver Dis"},{"issue":"6","key":"327_CR353","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1007\/s12274-020-2795-8","volume":"13","author":"J Wang","year":"2020","unstructured":"Wang J, Dang MN, Day ES. Inhibition of Wnt signaling by Frizzled7 antibody-coated nanoshells sensitizes triple-negative breast cancer cells to the autophagy regulator chloroquine. Nano Res. 2020;13(6):1693\u2013703. https:\/\/doi.org\/10.1007\/s12274-020-2795-8.","journal-title":"Nano Res"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-025-00327-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-025-00327-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-025-00327-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:46:03Z","timestamp":1761101163000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-025-00327-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":353,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["327"],"URL":"https:\/\/doi.org\/10.1186\/s43556-025-00327-x","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"22 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author declares no competing financial interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"83"}}